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1.1 Anatomy of the eye
Visual pathway
Light from an object enters the eye through the strongly light-refracting cornea (Figure 
1.1) and passes the anterior chamber and the pupil, the small opening in the iris.
The pathway of the beams then continues through the lens, which ideally refracts the 
light in such a manner, that it is focussed on the photoreceptor cells in the retina after 
its passage of the vitreous body. The photoreceptor cells then convert the light into a 
neuronal signal that is transmitted to the visual brain cortex in the occipital lobes. The 
pathway in the retina leads from the photoreceptor cells, through the bipolar cells, to 
the ganglion cells. The axons of these cells form the optic nerve and -via the optic 
chiasm and the optic tract- extend to the lateral geniculate body. Finally, the optic 
radiation passes the signal on to the occipital cortex.
Horizontal communication between the parallel pathways in the retina is possible via 
the horizontal cells and amacrine cells.
Anatomy
The eye itself consists of three layers: the outer shell formed by the sclera, with at the 
frontside the transparent cornea, secondly the uveal layer consisting of the iris, ciliary 
body and the large choroid –the latter closely attached to the sclera, and containing 
the outer retina-nourishing choriocapillaris-, and finally the retinal layer. This layer is 
directly attached to the choroid and anteriorly ends in the ora serrata at the beginning 
of pars plana of the ciliary body. The central retinal vessels in this layer, originating 
from the central retinal artery that branches from the ophthalmic artery, nourish the 
inner part of the retina. In about 15% of all individuals, however, part of the posterior 
Figure 1.1 Anatomy of the eye
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pole of both eyes is supplied by a cilioretinal artery originating from the choroidal 
vasculature through the temporal part of the optic nervehead. Unilateral cilioretinal 
(co-)vascularisation of the posterior pole is found in an additional 34.9%.1
The inner eye structures divide the interior of the eye in three compartments, as visible 
in Figure 1.2. The anterior chamber is divided from the posterior chamber by the iris 
plane, which in its turn is divided from the vitreous cavity by the lens and the plane 
formed by the threadlike zonules of Zinn, that surround the periphery of the lens and 
keep it in its place. The other ends of the zonules are attached to the pars plicata of 
the ciliary body.
The anterior and posterior chambers are filled with the aqueous fluid, which is 
produced by the ciliary body, and which nourishes the lens and cornea. The balance 
between the production of the aqueous and the drainage via the trabecular meshwork 
in the sharp angle formed by the cornea and the iris in the anterior chamber results in 
a certain ocular pressure.
Figure 1.3 Soluble proteins and hyaluronic acid in the collagen fibre meshwork in the vitreous 
body
I    II       III
Outer shell
Uveal layer
Retinal Layer
Figure 1.2 The three layers dividing the eye in three compartments
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The vitreous cavity is filled with a transparent gel-like substance: the vitreous body, 
which consists of a large quantity of water (about 99%) with a solution of salts, soluble 
proteins and hyaluronic acid contained in a meshwork of collagen fibres, mostly of 
the type II collagen. (See Figure 1.3) In young healthy eyes, this substance fills the 
complete vitreous cavity and is in contact with its surrounding structures: the retina, 
the ciliary body, the lens zonulae and the posterior surface of the lens.
The vitreous is most strongly attached to the retina at the vitreous base: a 2-6 mm 
wide circumferential zone of concentrated collagen fibrils covering the ora serrata, 
which anteriorly extends to the adjacent epithelium of the pars plana and posteriorly 
extends to the peripheral retina. (See Figure 1.4) Along the peripheral margin of the 
optic nervehead, a second relatively strong attachment of the vitreous to the retina is 
formed by vitreous fibrils that intermingle with the thickened basement membrane of 
the retina, but it is less firm than at the vitreous base.
Histology of the retina
Histologically, the retina consists of ten layers (Figure 1.5). The retinal layer directly 
attached to the choroid is the retinal pigment epithelium (RPE). Both this layer and 
the tight junctions of the vascular endothelium of the capillaries form a strong barrier 
between the bloodcells and the photoreceptor cells. They are part of the blood-brain 
barrier.
The remaining nine layers form the sensory retina. Numbered from the outside to 
the inside these nine layers are: 1. the photoreceptor layer, containing the outer and 
inner segments of the rods and cones; 2. the external limiting membrane, composed 
of the closely apposed processes of Müller cells from the fifth layer; 3. the outer 
nuclear layer, containing the cell bodies of the photoreceptor cells; 4. the outer 
plexiform layer, the zone of synapses between the interneurons (horizontal, bipolar 
Figure 1.4 The vitreous base, covering the ora serrata
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and amacrine cells) and the photoreceptors; 5. the inner nuclear layer, composed of 
the cell bodies of the interneurons and Müller cells; 6. the inner plexiform layer, the 
zone of synapses between the interneurons and the ganglion cells; 7. the ganglion 
cell layer, containing the cell bodies of the ganglion cells; 8. the nerve fiber layer, 
composed of the unmyelinated axons of the ganglion cells that course towards the 
optic disc; and 9. the internal limiting membrane, like the external limiting membrane 
formed by the apposed processes of the same Müller cells. This pattern of layers is 
found throughout the retina, except in the fovea.
Certain parts of the posterior retina are described as the macula, the fovea and the 
foveola (Figure 1.6). The anatomic macula is the posterior part of the retina containing 
the yellow xanthophyll pigment and two or more layers of nuclei in the ganglion cell 
layer. The area, vertically centered between the temporal vascular arcades at about 4.0 
mm temporal and 0.8 mm inferior to the center of the optic disc, is usually 5-6 mm in 
diameter and is responsible for the most refined levels of visual acuity and for color 
vision.
The 1.5 mm diametered macular center, anatomically characterized by a depression in 
the inner retinal surface, is the anatomical fovea. Its central floor is called the foveola, 
and is an area 0.35 mm in diameter. In this area, the inner retinal layers (inner nuclear 
layer and ganglion cell layer) as well as the retinal capillaries are absent, and the axons 
of the photoreceptors almost immediately bend away from the photoreceptor bodies, 
nearly parallel to the retinal surface, thereby minimizing light scatter.
Vitreous body
Ganglion cell layer
Inner plexiform layer
Inner nuclear layer
Outer plexiform layer
Outer nuclear layer
Receptor layer
Pigmented epithelium
Choroid
Outer limiting membrane
Inner limiting membrane
Figure 1.5 The ten layers of the retina and the adjacent choroid
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Photoreceptors
The photoreceptor cells are not equally spread over the retina: the density of 
photoreceptors is highest in and near the macula as shown in Figure 1.7.
Except in the fovea, where only cones are found, the photoreceptor layer contains two 
types of photoreceptors: the rods and the cones. The rods are responsible for contrast, 
brightness and motion sense, whereas the cones provide colour vision, fine resolution 
and spatial resolution. In humans, the rods represent 95% of the photoreceptors, where 
cones represent only 5%.
Figure 1.7 Photoreceptor density in the retina
Figure 1.6 The positions of macula, fovea and foveola in the posterior pole of the eye
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Figure 1.7 Photoreceptor density in the retina
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1.2 Retinal detachment
1.2.1 Definition
Retinal detachment is the situation in which fluid is present between the RPE and the 
photoreceptor layer. This situation can be the result of numerous processes.
Three main types of retinal detachment can be distinguished: the most common 
rhegmatogenous retinal detachment (RRD), the exudative retinal detachment and 
the tractional retinal detachment. The latter two types of detachment are sometimes 
referred to as “nonrhegmatogenous” or “secondary” detachments. Mixed types, 
however, are possible.
1.2.2 Types of retinal detachment
The term rhegmatogenous retinal detachment is derived from the Greek word 
“rhegma”, which means “rent” or “fissure”, referring to the occurrence of a retinal 
break, through which fluid from the vitreous cavity enters the subretinal space and 
thereby divides the sensory retina from the RPE. See Figure 1.8.
In exudative retinal detachment, the detachment is due to a subretinal fluid producing 
process, such as an inflammation or a tumor, and a retinal break is not involved.
In a tractional retinal detachment, the traction is caused by pathologic vitreoretinal 
adhesions, mechanically pulling the retina away from the RPE. Common causes for 
this type of retinal detachment are proliferative diabetic retinopathy, proliferative 
vitreoretinopathy (PVR), and penetrating traumata. Other less common causes such 
as retinopathy of prematurity and proliferative sickle cell retinopathy have been 
described.
The rhegmatogenous retinal detachment is the most common type of detachment, and 
the main scope of this thesis.
Figure 1.8 Retinal detachment caused by a flap tear
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Figure 1.9 Occurrence of RRD in relation to age
1.2.3 Epidemiology of RRD
The approximate yearly incidence of RRD is 10 per 100,000 individuals, but this 
number can vary between different races. The highest reported incidence rate was 
17.9 per 100,000 individuals per year in a white population in Minnesota, whereas 
the lowest reported annual incidence rate was 0.46 per 100,000 individuals, reported 
in South-African blacks.2;3 Swedish Caucasians, Chinese, Malay and Indians have 
incidences of 14.0, 11.6, 7.0 and 3.9 per 100,000 individuals per year respectively.4;5
Most RRDs occur between 40 and 70 years of age (Figure 1.9), and males represent 
approximately 57-60% of RRD patients.2;6-8 The overall mean age at diagnosis of 
RRD is 50 years for men and 59 years for women.2 For idiopathic, nontraumatic RRD 
alone, however, the mean age difference between the two sexes is not significant: 53 
and 56 years for men and women respectively.2;7
Although RRD is slightly more often reported in the right eye than in the left eye, 
no significant difference was found.7;9 RRD in the fellow eye -not necessarily 
simultaneously- has been reported in 4.2-19% of the cases.2;7;10;11 In the first year after 
the first RRD, a 2.1% rate has been reported in the fellow eye.11
1.2.4 Retinal breaks
RRD is caused by one or more retinal breaks: full-thickness defects in the neurosensory 
retina, which are designated ‘symptomatic’ if the patient reports photopsia and/or 
floaters. Asymptomatic retinal breaks are found in 5.8% of patients of 10 years or 
,
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older.12
Three main types of retinal breaks can be distinguished: flap tears, holes and retinal 
dialysis.8
Flap tears
Flap tears are caused by retinal traction from vitreous adhesions and are often found 
at the equator of the eye. Approximately half of the flap tears progress to RRD.13;14 
Appearances of tears range from a rarely seen slit-like shape to a more frequently seen 
complete horseshoe-shape. A tear that circumferentially extends 90 degrees of the eye 
or more is classified as a giant tear.
Holes
In some cases, the flap is completely torn free from the retina, leading to a hole with an 
operculum (lid) adhering to the posterior vitreous membrane. These operculated holes 
tend to occur more posteriorly than flap tears. Because of the loss of traction on the 
retina after separation of the operculum, they are less apt to cause retinal detachment 
than the usual tears.8
Holes without an operculum are caused by a different mechanism. They are mostly 
due to gradual atrophy of the retina, and are often found in the equatorial zone or near 
the ora serrata, in the middle of areas with lattice degeneration, or in association with 
retinoschisis and chorioretinal atrophy. Rarely, they are caused by ruptured cystoid 
spaces in peripheral cystoid degeneration. Asymptomatic operculated and atrophic 
holes are considered quite harmless, and only very rarely lead to RRD.15
Macular holes are caused by degeneration or fusion of intraretinal cystoid spaces and 
also only rarely cause retinal detachment.
Retinal dialysis
A retinal dialysis is a linear, circumferential break found at the ora serrata, and is 
commonly caused by blunt traumata.
The break types differ in retinal distribution of the breaks: flap tears are most often 
found in the superior quadrants of the retina, more often in the temporal part. Atrophic 
retinal holes are also most often found in the temporal quadrants, but as in flap tears, 
they most often appear in the superior part. Retinal dialyses are most frequently found 
in the inferior temporal quadrant. Furthermore, most retinal breaks are found near 
the equator (45%) or anteriorly to the equator (12% at the ora serrata, 28% between 
the ora and the equator); the rest appears more posteriorly, and only 1% occurs at the 
macula.8
1.2.5 Risk factors
The known risk factors for RRD can be divided in endogenous factors like myopia, 
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vitreous degeneration and lattice, and acquired factors like trauma and aphakia or 
pseudophakia.
Myopia
Myopia is found in approximately 56% of all detachment patients. The refractive 
error in most patients is not lower than –3 diopters, but higher degrees of myopia are 
associated with higher lifetime risks for RRD. These risks go up to 9.3% for refractive 
errors of –5 diopters or less, as shown in Figure 1.10.16;17 Furthermore, younger RRD 
patients tend to have more myopic refractive errors, whereas older patients tend to 
have refractive errors closer to emmetropia.16;17
Vitreous degeneration
Degeneration of the vitreous body is a physiological process seen in aging. (See 
Figure 1.11) A progressive liquefaction process of the vitreous starts in the posterior 
part, in front of the macular region, and gradually spreads to the anterior parts. This 
results in a gradual ‘fibrous destruction’ and formation of optically empty lacunae 
filled with liquid vitreous in the normally gel-like vitreous body of a young healthy 
eye. This process is associated with posterior vitreous detachment, which is usually 
found in eyes with liquefaction of more than half of the vitreous body.18;19 This usually 
acute event of posterior vitreous detachment is associated with vitreoretinal traction 
at the undetached sites, especially in the peripheral retina where the vitreous base is 
located and where the collagenous adhesion to the retina is strongest. This process 
leads to retinal breaks in 14% of patients and finally results in RRD in 28% of these 
patients.20;21 Posterior vitreous detachment is found in less than 10% of individuals 
under 60 years of age, in 27% of individuals between 60 and 70, and in 63% of 
individuals of 70 years and above.19
Figure 1.10 Lifetime risks of retinal detachment in relation to refractive error25
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Lattice degeneration
Lattice degeneration is found in approximately 7-11% of the general population. Most 
of these people will never develop RRDs and an overall lifetime risk of only 0.5% was 
estimated.22 However, about one-third of all phakic RRDs is associated with lattice 
degeneration; especially younger age groups with lattice and groups with myopia 
might develop RRD. The presence of lattice degeneration in myopic patients increases 
the annual incidence of detachment by a factor of approximately 10. The higher the 
degree of myopia in the presence of lattice, the higher the lifetime risk for RRD. These 
risks even go up to 35.9% for myopia lower than –5 diopters, whereas emmetropic or 
hyperopic eyes with lattice degeneration have a lifetime risk of 1.7%.17
Trauma
Blunt or perforating trauma-related RRD is seen in 11.6% of RRDs, and has an annual 
incidence of 1.3 per 100,000 individuals.2 In an independent study, these numbers are 
respectively 8% and 0.93 per 100,000 individuals for blunt traumata only.7 The age 
of these patients is three to four decades lower than usual in RRD, and this RRD-type 
is found 5-11 times more often seen in males in comparison to females.2;7 In juvenile 
 A  B
 C  D
Figure 1.11 Stages of vitreous degeneration 
A: The vitreous body has a gel-like consistency and is attached to the complete retina. B: 
The vitreous body liquefies, and starting in the posterior part, lacunae develop. C: Further 
liquefaction causes a lacunar break, enabling the liquid to pass through the break. D: A posterior 
vitreous detachment develops, possibly causing traction on or even a break in the retina.
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RRD, trauma is the cause in 44% of patients.23 
Cataract surgery
The incidence of retinal detachment following cataract surgery ranges from 0.6% to 
1.7% during the first postoperative year. After 10 years, the risk is 5.5 times higher 
in patients who have undergone cataract surgery compared to unoperated patients. In 
intracapsular cataract extraction the estimated overall incidence of retinal detachment 
ranges between 1-8.1% after follow-up of between 1 week and 22 years. A higher 
incidence of retinal detachment after intracapsular cataract extraction in myopic eyes 
(around 6%) than in non-myopic eyes (1.1-3.6%) was reported. Likewise, retinal 
detachment was more often reported in aphakic eyes (2.8%) compared to eyes with 
an implanted intraocular lens (0.2%). In extracapsular cataract extraction, a slightly 
lower RRD incidence of 0-7.5% (but mostly around 1%) was estimated, which –
in comparing studies- was even lower in operations using phacoemulsification (0-
3.6%).
The most important factor following cataract extraction probably is the posterior 
vitreous detachment, which is more commonly seen in patients in whom the lens 
has been removed. Furthermore, lower concentrations of hyaluronic acid in aphakic 
eyes compared to phakic fellow eyes in humans, as well as in intracapsular cataract 
extraction compared to extracapsular cataract extraction in monkeys have been found, 
suggesting a role of the posterior capsule and/or the hyaluronic acid in maintaining the 
colloidal structure of the vitreous.24
Capsulotomy
Posterior capsulotomy using Nd:YAG laser (which is the short name for the laser 
that uses a rod of yttrium alumininium garnate containing ions of neodymium as the 
amplifying medium) treatment has also been associated with an increased risk of retinal 
detachment of between 0% and 4.1% after a 3 months to 4 year follow-up, and is often 
performed to resolve opacifications of the posterior lens capsule after extracapsular 
cataract extraction. This unfortunately hampers accurate estimates of Nd:YAG laser 
complications isolated from those of extracapsular cataract extraction.24
1.2.6 Natural history of RRD
Untreated RRDs invariably lead to marked proliferative vitreoretinopathy, which can 
provide new traction upon the retina leading to fixated retinal folds, (new) breaks and 
further detachment. The result can be permanent loss of vision with maximal visual 
acuities of hand movements. The latter is due to the progression of the RRD, which 
usually starts with one or more retinal breaks in the periphery of the retina with no 
or scanty subretinal fluid. Due to gravity forces and the limited subretinal space, it 
spreads towards the macular region, until finally the retina is detached completely, 
except around the papilla. (See Figure 1.12) Other associated complications of long-
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standing RRD are hypotony, cataract, strabismus, low-grade iridocyclitis, rubeosis 
iridis and phthisis bulbi.25
1.2.7 Treatment
The goal of treatment is to achieve reattachment of the neurosensory retina to the 
retinal pigment epithelium with its underlying choroids, and to prevent the eye from 
further leakage of subretinal fluid.
Laser coagulation and cryocoagulation
Laser coagulation in cases of clear intra-ocular media and transscleral cryocoagulation 
in cases of troubled media can be used to create a firm chorioretinal adhesion by 
inducement of a scarring process. The techniques are used in cases with retinal 
breaks without clinical retinal detachment to prevent further leakage of subretinal 
fluid, or in cases where a firm reattachment is needed after surgical realignment of the 
neurosensory retina and the retinal pigment epithelium. Laser treatment is successful 
in prevention of progression to RRD in over 95% of cases.26
Surgical treatment
In case of an apparent RRD, surgical treatment is needed. Scleral buckling is the most 
conventional procedure for a local RRD: a silicon buckle is placed around the eye 
at the site of the retinal break(s), parallel to the corneal limbus. One or more silicon 
patches (“plombes”) are placed between sclera and buckle at the sites of the breaks, 
thereby causing a local indentation that joins the retinal pigment epithelium and the 
retinal break. See Figure 1.13.
Additional transscleral punction can be used to drain the accumulated subretinal 
fluid, and a slowly resorbing gas can be injected into the vitreous cavity for additional 
Figure 1.12 Complete retinal detachment. 
Note that the papilla centers all folds.
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pressure from within the eye and tamponade of the retinal break.
As a second method of treatment for a local RRD, this gas injection is also used 
without the buckling procedure: a procedure known as pneumatic retinopexy. The 
procedure is often preceded by cryocoagulation of the defect, and followed by laser 
treatment. During 5-7 days, patients are requested to position their head in a way that 
allows the gas bubble to tamponade the retinal break. After one retinopexy, 73% of the 
detachments is successfully reattached.27
Vitrectomy is applied in the more complicated detachments. The vitreous body and the 
retinal traction are removed using instruments entering the vitreous cavity via three 
scleral incisions through the pars plana of the ciliary body, enabling repositioning of 
the retina. Additionally, transscleral punction of accumulated subretinal fluid, laser- or 
cryotherapy can be used. The vitreous is temporarily replaced by a slowly resorbing 
gas, or by silicon oil that has to be removed surgically at a later time, to keep the retina 
in its place. The procedure can be combined with the buckling procedure.
Sometimes, several operations are needed to achieve final reattachment of the retina: 
a primary reattachment is achieved in about 76-85%.28 If timely surgical treatment is 
given, an anatomically good result can be achieved in 90-96% of cases.28-31
Figure 1.13 Scleral buckling with a radial and a limbus-parallel silicon patch
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1.3 Genetics of retinal detachment
Retinal detachment can be part of genetic disorders with or without systemic 
abnormalities. Due to overlapping symptoms of these disorders, a strict distinction 
between syndromes is often very difficult, and can sometimes only be made after a 
certain period of follow-up.
For the clarity of the description below, however, the most important disorders are 
divided in two groups, according to the presence or absence of non-ocular (systemic) 
abnormalities. We respectively refer to them as syndromic or nonsyndromic 
disorders.
1.3.1 Nonsyndromic disorders with retinal detachment
1.3.1.1 High myopia
High or “pathologic” myopia of ≤ -6.00 diopters has a worldwide prevalence ranging 
from 0.1-2.5%, with exceptions of 9.1% in Singaporean Chinese, 9.6% in Spaniards 
and 21% in Taiwanese students, although Taiwanese elderly showed the usual 
prevalence of 2.4%. Furthermore, females had significantly higher rates than males.32-
41 It is primarily caused by increased ocular axial length and may be associated with 
glaucoma, macular degeneration, cataract and retinal detachment. Other causes are 
corneal or conical changes of the lens. Furthermore, both environmental factors 
(such as near work and years of education) and genetic factors (from both population 
and twin studies) have been implicated as causes for myopic changes in refractive 
error, but heredity seems to play a more important role in high myopia than in low 
myopia.35;42-46
Autosomal dominant pathologic myopia loci were found at chromosome 18p11.31 
(MYP2), chromosome 12q21-q23 (MYP3), chromosome 7q36 (MYP4), and 
chromosome 17q21-q22 (MYP5).47-50 The X-linked form of high myopia, Bornholm 
Eye Disease, showed linkage with chromosome Xq28 (MYP1) and was accompanied 
by moderate hypoplasia of the optic nerve heads and deuteranopia in all affected 
males.51 Strikingly, no genes underlying high myopia have thus far been indentified.
1.3.1.2 Vitreoretinopathies
Wagner disease
Wagner disease was first described in 1938 and is an autosomal dominantly inherited 
disorder with a usually moderate myopia around –3 to –4 diopters, vitreoretinal 
abnormalities and a complicated cataract that starts in adolescence and which needs 
extraction around the fourth decade of life.52 The eye characteristically shows a very 
liquid vitreous body that seems optically empty upon slit-lamp biomicroscopy, with an 
exception of a few threads with very small white dots. A preretinal circular membrane 
of variable widths -sometimes as thin as a line- at the equator is found in all affected. 
It is, however, not always complete and the peripheral boundaries are not always 
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markedly visible. See Figure 1.14. 
In an early stadium of the degenerative process of the vitreous body, fibrillar 
condensations are common, whereas avascular strands and veils are more common 
among patients older than 30 years of age.
Additional observations are peripheral perivascular hyperpigmented spots in the retina 
with white vascular sheating, choroidal atrophy, sclerosis of the vessels, pallor of the 
optic disc or atrophy of the optic nerve and reduced night vision. An abnormal pattern 
of the central retinal vessels (“situs inversus” or “dragged vessels”) was found in half 
of the patients (Figure 1.15).
Fluorescein angiography shows loss of the choriocapillaris and the RPE, with 
preservation of larger choroidal vessels. Visual fields are concentrically reduced, dark 
adaptations range from almost normal to strongly reduced values, and scotopic ERG 
testing reveals subnormal values between 50-100 mV and a prolonged implicit time. 
Skeletal, cardiovascular or hearing abnormalities are not found.52-55
Figure 1.15 Situs inversus of the central retinal vessels in a patient with Wagner disease
Figure 1.14 Preretinal circular line at the equator in a patient with Wagner disease (arrow)
←
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Rhegmatogenous retinal detachment, due to flap tears and/or atrophic holes, is 
described in approximately 15% of patients at an average age of 20 years. Peripheral 
tractional retinal detachment is described in approximately 35% of patients at an 
average age of 49 years. Some of these tractional detachments are bilateral.54 A 
subtype of Wagner disease with more frequent retinal detachments was described by 
Jansen, and is sometimes referred to as Jansen syndrome.56 This subtype was initially 
thought to be distinct from Wagner disease because retinal detachments had not been 
described in the original Wagner pedigree, but later follow-up of this pedigree showed 
retinal detachments after all.54
Linkage analysis proved an association with chromosome 5q13-1457, and later studies 
that among others included one of the families described by Jansen, achieved further 
refinement to a 2- to 2.5-cM region of chromosome 5q14.3.58;59 The responsible gene, 
however, has not yet been found.
Erosive vitreoretinopathy
The in 1993 first described erosive vitreoretinopathy is inherited in an autosomal 
dominant fashion, and is characterized by pronounced vitreous syneretic abnormalities, 
frequently complicated retinal detachments, and a marked progressive pigmentary 
retinal dystrophy.60
The first symptoms in patients are night vision difficulties and progressive constriction 
of the visual field, mostly starting in young adulthood. Refractive errors vary from 
emmetropia to –10 diopters, and a nuclear sclerotic cataract requiring extraction of 
the lens by 40 years of age is common, although this might also be caused by the high 
incidence of surgery for retinal detachment. Ophthalmoscopy shows marked equatorial 
RPE thinning or ‘erosion’ in the course of time enabling visualization of the choroidal 
vessels, as well as thick rope-like strands, sheets or veils, often with traction at the 
border of erosive lesions an normal-appearing RPE. Some patients additionally show 
attenuated, sheathed arterioles with retinal atrophy, as well as dragged disc vessels, an 
ectopic macula, a positive angle kappa and peripheral retinoschisis.
Retinal detachments can be both tractional and rhegmatogenous, and have an onset 
under 10 years of age in almost all patients. In about half of the cases they are bilateral. 
The detachments are often caused by multiple posterior breaks or giant retinal tears, 
and they are difficult to repair.
Corresponding with the RPE lesions, most eyes show complete or incomplete ring 
scotoma with progression to the centre. The ERG recordings for rods and cones are 
reduced, and under light-adapted circumstances, the 30-Hz flicker ERG is prolonged 
abnormally.
Linkage analysis in the erosive vitreoretinopathy family revealed association with 
a critical interval of 35 cM that overlaps the Wagner disease locus at chromosome 
5q13-q14. Therefore, erosive vitreoretinopathy and Wagner disease might be allelic 
disorders.57
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Snowflake vitreoretinal degeneration
Snowflake vitreoretinal degeneration was first described in 1974, and is character-
ized by early onset cataract, fibrillar degeneration of the vitreous and slowly progres-
sive peripheral retinal abnormalities resembling snowflakes: minute, shiny crystal-
linelike yellow-white deposits. Rhegmatogenous retinal detachment around the fifth 
decade of life or later is described in 21% of the patients, due to horseshoe tears or 
large holes at the equatorial retina. Additionally, corneal guttae, radial perivascular 
degeneration, vascular sheathing on and near the optic disk and chorioretinal atrophy 
between round or irregularly shaped peripheral pigment clumps at the posterior mar-
gin of the snowflake degeneration have been reported. In later stages the pigmented 
clumps are more pronounced, and the peripheral vessels seem to whiten and become 
less visible. Refractive errors range from slight hyperopia to –7 diopters, but the 
myopia is generally mild.61;62
The disease is autosomal dominantly inherited, and has not yet been associated with 
a certain chromosome. Linkage with the Wagner locus and several collagen genes 
associated with vitreoretinal degeneration (COL2A1, COL11A1, COL9A1, COL9A2 
and COL9A3) has been excluded.62
Familial exudative vitreoretinopathy
Familial exudative vitreoretinopathy, first described in 1969, is characterized by 
bilateral deficient vascularisation of the peripheral retina that can be visualized with 
fluorescein angiography. The phenotype, however, can be variable: from mild with 
retinal traction that straightens the temporal retinal vasculature and moderate with 
distortion and displacement of the macula and the vessels around the optic disk, to 
severe with traction leading to retinal folds and detachment.63;64 The retinal detachment 
usually occurs in the second or third decades of life, is seen in 20-32% of patients 
and can be tractional, exudative or rhegmatogenous in origin. The latter, however, 
is the most frequent.65;66 Other findings in patients are peripheral snowflake vitreous 
changes, and areas of normal retina except for the whiter aspect, appearing without 
(or upon) indentation called “white without (or with) pressure”. These “white without 
pressure” areas are only significant if a giant tear in the fellow eye has appeared: they 
may then be associated with an increased risk of retinal breaks.67 Although familial 
exudative vitreoretinopathy generally occurs bilaterally, the severity of the disease 
can be asymmetric.
In autosomal dominant familial exudative vitreoretinopathy, which is the most common 
type of inheritance66;68, two genes at the same locus EVR1 at chromosome 11q13-
q23 have been identified: the FZD4 gene and the LRP5 gene.69;70 FZD4 encodes the 
Wnt receptor frizzled-4, and LRP5 encodes low-density-lipoprotein receptor-related 
protein 5, a Wnt co-receptor. An additional locus, EVR3, for autosomal dominant 
familial exudative vitreoretinopathy has been found on chromosome 11p12-p13, but 
the gene remains unidentified.71 In the X-linked form of the disorder, mutations in the 
Norrie disease gene (ND) at the EVR2 locus at chromosome Xp11.3-p11.4 have been 
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described.72;73 Autosomal recessive inheritance of the disorder has been described in 
families, but the responsible loci has not yet been identified.74;75
1.3.1.3 Other disorders
X-linked juvenile retinoschisis
The first description of X-linked juvenile retinoschisis dates from 1898. The disorder 
usually presents with a deteriorated vision in childhood and shows a characteristic 
maculopathy with tiny superficial cystoid spaces in a stellate pattern surrounding the 
fovea, which can coalesce and in time will disappear and leave only a non-specific 
atrophic lesion in both macula and underlying RPE. In approximately 50% of patients 
a thin retinoschisis is present, consisting of the internal limiting membrane and the 
retinal nerve fibre layer. If defects develop in the layers of the schisis cavity or if a full-
thickness break develops in other areas, an RRD can develop. Retinal detachments are 
described in 0-23% of patients, mostly in the first two decades of life.76-78 Only few 
of these detachments are exudative.79 Another common complication of the disorder 
is a vitreous hemorrhage, due to ruptured retinal vessels in areas of retinoschisis. 
Most patients are hyperopic or emmetropic, but also myopic patients have been 
described.18;76 The disease was caused by mutations in the RS1 gene at Xp22.13, 
coding for retinoschisin. This protein is thought to be excreted by the photoreceptors, 
and speculated to be involved in either cell-cell interaction or adhesion, thereby 
contributing to the maintenance of the cellular architecture of the retina.80;81
Nonsyndromic Congenital Retinal Nonattachment
This disorder was first described in 1938, and inherits both autosomal dominantly 
and autosomal recessively. As the name suggests, a congenital unattached retina is 
seen in children. Other described ocular abnormalities related to the disorder are 
congenital light insensitivity, massive retrolental masse, shallow anterior chamber, 
microphthalmia and nystagmus. The responsible gene has not yet been identified, but 
linkage with chromosome 10q21 has been found.82;83
1.3.2 Syndromic disorders with retinal detachment
1.3.2.1 Stickler syndrome
The autosomal dominant Stickler syndrome was first described in 1965.84 The disorder 
comprises ocular abnormalities, hearing loss and skeletal abnormalities, although a 
non-ocular form of Stickler syndrome was also described. Ocular Stickler syndrome is 
diagnosed if a congenital vitreous anomaly consisting of either a retrolental membrane 
(type I) or irregular thickened (‘beaded’) fibrils (type II) exists, in combination with 
at least three of the following: (usually stable) myopia with onset before 6 years 
of age (a), rhegmatogenous retinal detachment or paravascular pigmented lattice 
degeneration (b), joint hypermobility with abnormal Beighton score, either with or 
without radiological evidence of joint degeneration (c), audiometric confirmation of 
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sensorineural hearing loss (d), and midline clefting (e). Other abnormalities such as 
cataract, midfacial hypoplasia, slender extremities, long fingers with normal body 
height, and mitral valve prolapse were also associated with the syndrome.85-87
The RRDs in Stickler syndrome are mostly found in children, adolescents or young 
adults, and appear in approximately 50% of patients with Stickler and are often 
bilateral.88 They usually result from giant retinal tears or multiple breaks in retinal 
areas with thinning of the RPE and lattice degeneration.85;89
Phenotypic variation within and between families is well known, although the vitreous 
abnormalities seem consistent in families and seem indicative for the causative 
genetic defects: the membranous vitreous anomaly is associated with mutations in 
the COL2A1 gene on chromosome 12q13.11-q13.2, whereas the beaded fibrillar 
anomaly is associated with mutations in the COL11A1 gene on chromosome 1p21.85 
However, the value of these observations and whether they always correctly indicate 
the causative gene is still subject of discussion, because a Stickler family with a 
membranous vitreous anomaly showed linkage with COL11A1, two Stickler families 
with a fibrillar anomaly showed no linkage with COL11A1, and a third afibrillar 
anomaly was described in a family with a COL2A1 mutation. Finally, only a minority 
of patients from a family with a known Stickler mutation in the COL2A1 gene showed 
a type I vitreous.90-94
Non-ocular Stickler syndrome has been associated with mutations in the COL11A2 
gene on chromosome 6p21.3, and a fourth locus for Stickler syndrome is suspected, 
because in some families mutations in all three known genes have been excluded.91;95-
97
1.3.2.2 Marshall syndrome
Whether Marshall syndrome is a distinct clinical entity from Stickler syndrome is 
still an unresolved issue; the facial appearance in the two syndromes seems to make 
the difference.98 The original family described in 1958 showed autosomal dominant 
inheritance of cataracts, high myopia, abnormal vitreous, pronounced midfacial 
hypoplasia and congenital deafness.99 Additional hypertelorism as a specific feature 
of the disorder was described100, and short stature, long philtrum, short nose and 
anteverted nostrils were associated with the syndrome.101 Whether ectodermal 
dysplasia, as suggested in the original family, is a feature of the condition is also 
still debated.  However, the hair in patients of the original family was normal, and 
hypodontia and hypohidrosis were not strongly and convincingly present, although 
the latter was estimated 25% lower than normal in patients.99
Rhegmatogenous retinal detachments were suggested to occur less frequently in 
Marshall syndrome than in Stickler syndrome.98;102
As in Stickler syndrome, mutations in the COL11A1 gene were found; splice site 
mutations in a 54-bp exon in the C-terminal end of the COL11A1 gene were associated 
with the Marshall syndrome phenotype, while other COL11A1 mutations caused a 
phenotype with features of both Marshall and Stickler syndrome.101;103
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1.3.2.3 Kniest dysplasia
Kniest dysplasia, first described in 1952, is a generalized disorder of connective tissue 
and is characterized by short-trunk dwarfism, kyphoscoliosis, prominent joints with 
restricted mobility, midface hypoplasia, cleft palate, hearing loss, combined with 
ocular abnormalities as prominent eyes, high myopia with vitreous liquefaction and 
syneresis and/or retinal detachment.104-107 Cartilage biopsies have disclosed a “Swiss 
cheese” appearance: empty spaces in the cartilage matrix, which is loosely woven and 
contains large chondrocytes.108
The retinal detachment develops in almost 50% of the patients, often before 6 years of 
age.18 The retinal defects can present as multiple tears in the periphery, as giant tears 
or as dialysis at the ora serrata.18;106
So far, all mutations responsible for the disease have been found in the COL2A1 
gene. It has been suggested that Kniest dysplasia results from shorter type II collagen 
monomers, and that alteration of a specific COL2A1 domain, which may span from 
exons 12 to 24, leads to the phenotype.109
1.3.2.4 Marfan syndrome
The Marfan syndrome, first described in 1896, is a usually autosomal dominant inherited 
disorder with a variable expression. The combination of cardiovascular abnormalities 
(such as dissection or dilatation of the ascending aorta and aortic regurgitation), the 
skeleton (such as long and thin limbs, arachnodactyly, pectus deformity, scoliosis and 
laxity of the joints) and the eye (such as dislocated lenses, axial myopia, flat cornea, 
hypoplastic iris or ciliary muscle, liquefaction of the vitreous, peripheral retinal 
changes, lattice degeneration and retinal holes) is classic. Lately, lumbosacral dural 
ectasia has become one of the major criteria. Additional abnormalities can be found in 
the pulmonary system or skin.110-113
RRDs were seen in 3.5-25% of Marfan syndrome patients and were mostly caused 
by multiple retinal tears, but also by holes or oral dialysis.114-121 Bilateral detachments 
were seen in 34.5% of patients.121
The syndrome is caused by mutations in the fibrillin (FBN-1) gene, residing at 
chromosome 15q21.1.122-124
1.3.2.5 Knobloch syndrome
Knobloch syndrome is a rare autosomal recessive disorder, first described in 1971, and 
characterized by high myopia, macular abnormalities, vitreoretinal degeneration with 
retinal detachment, macular abnormalities and occipital encephalocele. The expression 
of the syndrome is variable within or between families, but shows a 100% penetrance.125-
128 Other abnormalities in single families comprise lens subluxation, cataracts, flat 
nasal bridge, midface hypoplasia, bilateral epicanthic folds, hyperextensible joints, 
right lung hypoplasia with anomalous pulmonary return, cardiac dextroversion, 
unilateral duplicated renal collecting system and unusual palmar creases.125-129
Rhegmatogenous retinal detachments in the original family were seen under ten years 
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of age, were often bilateral and were caused by multiple tears, some with rolled edges, 
or by a giant tear.130
Homozygous mutations have been found in the COL18A1 gene at chromosome 
21q22.3, but another locus is suspected, as in some families and single patients 
mutations in the COL18A1 gene have been excluded.131;132
1.3.2.6 Other disorders
In Norrie disease, congenital degenerative and proliferative changes in the neuroretina 
and vitreous lead to a disorganized neuroretina, vitreoretinal haemorrhages and 
leukocoria due to retrolental fibrovascular masses, retinal folding and detachment. 
Finally, this process results in progressive ocular atrophy and blindness. Mental 
retardation and sensorineural deafness develop in one-third of all patients, and a 
wide inter- and intrafamilial variety of severity and clinical course of the disorder 
is known.18;133 The inheritance is X-chromosomal, and mutations in the ND gene at 
chromosome Xp11.4 are causative for the disease.133
Retinal detachments are also described in diabetes mellitus, in which genetic 
predisposition is suspected and considerable heterogeneity exists, making the 
determination of the exact modes of inheritance difficult and unclear. These retinal 
detachments can be both tractional and rhegmatogenous, which is also the case 
in sickling hemoglobinopathies.18;134 RRDs were rarely reported in patients with 
homocystinuria, which inherits in an autosomal recessive way, and in patients with 
Ehlers-Danlos syndrome, of which many subtypes exist, and which can be inherited 
either autosomal dominantly, autosomal recessively or X-chromosomal.18;115;135
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1.4 Aims of this thesis
Although knowledge about the inheritance of syndromes with retinal detachment has 
strongly grown during the last decades, little is known about nonsyndromic forms of 
inherited retinal detachment. During the last few decades, the knowledge about and 
experience in techniques for surgical treatment and prevention of retinal detachment 
has also expanded enormously, possibly enabling prevention or early treatment in 
patients at risk by inheritance.
We tried to investigate the magnitude of the genetic risk of nonsyndromic RRD and 
the risk for relatives of patients with RRD, which is described in Chapter 2.
To investigate possible differences in presentation and in surgical prognosis with 
regular RRDs, we have clinically studied two large families with autosomal dominant 
nonsyndromic retinal detachments, as described in Chapter 3.
To identify the gene(s) involved in retinal detachment, we studied these two large 
families with autosomal dominant nonsyndromic retinal detachments. Linkage 
analysis showed linkage of the disorder with a chromosomal region on chromosome 
12 containing the COL2A1 gene in both families. This gene indeed showed a mutation 
in one of these families, as described in Chapter 4.
To investigate if the COL2A1 gene was involved in other families with retinal 
detachments, and, if so, to what extent, we studied smaller multiplex families with at 
least three retinal detachments in at least two generations. This study is described in 
Chapter 5.
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2.1 Abstract
Objective:
To investigate the magnitude of the genetic risk of nonsyndromic rhegmatogenous 
retinal detachments (RRD) in a familial aggregation study.
Design:
Two hundred three consecutive patients with RRD and 461 controls without RRD 
were ascertained at the Department of Ophthalmology of the University Medical 
Centre Nijmegen in Nijmegen, the Netherlands. Data on family composition, history 
of RRD, and presence of other risk factors in siblings and offspring were collected by 
means of a questionnaire. Diagnosis of RRD was confirmed by evaluation of medical 
records.
Results:
One hundred eighty-one  patients (89.2% of eligibles) and 408 controls (88.5% of 
invited controls) with 1090 and 2345 relatives, respectively, were included in the 
analysis. Thirteen  familial RRDs (1.2%) were diagnosed in 10 case probands and 
9 RRDs (0.4%) in 8 control probands. Siblings and offspring of cases had a higher 
incidence of RRD independent of age, sex, and myopia. The cumulative lifetime risk 
of RRD was 7.7% for relatives of cases and 3.0% for relatives of controls, yielding a 
risk ratio of 2.6 (95% confidence interval, 1.1-6.2).
Conclusions:
Familial occurrence of RRD is a risk factor for RRD. Genetic factors apart from 
myopia may explain the increased familial risk.
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2.2 Introduction
Rhegmatogenous retinal detachment (RRD) is a common retinal disorder with an 
incidence of 1 per 10,000 individuals per year in Caucasians.1-3 Untreated, RRD can 
lead to irreversible damage of the rods and cones, frequently ending in blindness.4 
Conversely, surgical treatment can achieve reattachment of the retina in 90 to 96% 
of cases when performed in a timely manner.5-8 Prevention of RRD, however, is 
preferable. Preventive laser treatment and encirclement can be used in individuals 
with a known high risk of RRD.
Known endogenous risk factors for RRD are myopia, lattice degeneration and posterior 
vitreous detachment, while acquired risk factors such as trauma and prior cataract 
surgery can also contribute considerably to the risk of RRD. Furthermore, RRDs are 
more often found in men (57-60%) than in women9;10, and race has proven to be an 
important determinant. A recent study showed that Chinese had an annual incidence 
of 11.6 per 100,000 individuals, Malays had an incidence of 7.0 per 100,000, and 
Indians had an incidence 3.9 per 100,000.11 Blacks had an extremely low incidence; 
in black South-Africans, the incidence was reported to be as low as 0.46 per 100,000 
individuals.12 These racial differences may result from genetic disparity.
There is now ample evidence that retinal disorders related to RRD carry a genetic 
component. Case reports and twin studies have shown that retinal dialysis, idiopathic 
giant tears, lattice degeneration, and myopia can aggregate in families or can show 
a remarkable resemblance among relatives.13-18 The genetic risk for myopia has been 
studied most profoundly, and a fifth genetic locus for high myopia was found recently.19 
Multiple RRDs, both with and without myopia, have been described in families. Some 
of these revealed inherited syndromic etiologies such as Wagner disease20, erosive 
vitreoretinopathy21 or Stickler syndrome22, but others had no known syndromic cause 
of RRD.23-25 Recently, we found evidence for genetic linkage in two large autosomal 
dominant RRD families without systemic abnormalities.26
Although genetic susceptibility to RRD appears to be present in specific families, it 
is currently unknown whether RRD occurring in a general population has a genetic 
etiology. The purpose of this study was to investigate the magnitude of the genetic 
risk of common, nonsyndromic RRD. We studied aggregation of RRD in siblings 
and offspring of probands with RRD that was not associated with other disorders, in 
comparison with siblings and offspring of healthy controls. In addition, we estimated 
the risk for first degree relatives independent of other risk factors.
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2.3 Methods
The initial phase of the study, the selection of probands, had a case-control design. This 
was subsequently followed by construction of two cohorts of first-degree relatives for 
analysis.
Collection of probands
Probands were ascertained at the department of Ophthalmology of the University 
Medical Centre Nijmegen in Nijmegen, the Netherlands. The case group was composed 
of all consecutive patients with RRD who were hospitalized from June to December 
2000. Exclusion criteria were non-Caucasian race; inherited retinal detachment-
causing syndromes like Marfan, Wagner, Stickler and juvenile retinoschisis; and 
RRDs occurring less than 4 years after intra-ocular operations or ocular traumata.
The control group was composed of Caucasian companions of patients who were 
visiting our department for reasons other than RRD, who were not related to the 
patient-group, and who were matched within a five-year age range with case 
probands. Exclusion criteria for control probands were history of retinal detachment 
or (family) history of retinal detachment-causing syndromes, clinical symptoms 
of retinal detachment at the time of inclusion, and participation of relatives in the 
case group. Diagnoses of ophthalmologic disorders among the control-group were 
checked by medical records where appropriate. The study was executed according 
to the guidelines of the Committee on Research Involving Human Subjects Region 
Arnhem-Nijmegen, and written consent was obtained from all participants.
Data collection and diagnosis of RRD in relatives
Probands filled out a questionnaire regarding personal medical history, present 
symptoms of retinal detachment, and risk factors for RRD. The spherical equivalents 
of glasses or contact lenses were measured or collected from ophthalmologic records 
to obtain information about the presence and degree of myopia. The pre-operative 
refractive errors were used to assess myopia in subjects who had undergone cataract 
surgery. Myopia was defined as a spherical equivalent of -1,00 D or less in at least 
one eye.
Size, composition and ophthalmologic history of siblings and offspring of the proband 
were ascertained by questionnaire and subsequent personal follow-up by telephone 
by one of the investigators (SLG). Probands were asked for the ophthalmic history 
of each relative (e.g., a diagnosis of RRD, name of treating ophthalmologist, cataract 
extraction preceding RRD, trauma or other ophthalmologic events, and presence of 
myopia, as well as age at last contact). After informed consent and written permission 
of the affected relatives or their legal representatives was obtained, medical files 
of the ophthalmologists were collected in all subjects with histories of RRD and 
possible RRD-related disorders. A final diagnosis of RRD in relatives was given after 
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evaluation of these records by two independent retinal specialists (CBH and CCWK). 
Relatives of probands were excluded if they had never had contact with the proband, 
if their retinal detachment was due to a perforating trauma, or if the RRD was non-
rhegmatogenous in origin.
Statistical analysis
Demographic and clinical characteristics were compared with t test for continuous 
variables and with χ2 test for categorical variables. Cox proportional hazards 
regression analysis was used to estimate the risk of RRD for first-degree relatives 
of cases independent of the confounding factors age, sex, and myopia. First-degree 
relatives of controls served as the reference. Each relative with RRD was tallied as 
a single event. The cumulative risk estimating the lifetime absolute risk of RRD for 
first-degree relatives was calculated with Cox proportional hazards analysis at age 85 
years. Study participants 85 years or older were pooled to avoid biased estimates.27
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2.4 Results
Family description 
Of all consecutive 271 RRD cases that had been treated in the study period, a total of 
68 cases were excluded because of inherited retinal detachment-causing syndromes (1 
case), intra-ocular surgery within 4 years before the detachment (54 cases) or trauma 
(13 cases). The proband group that was eligible for our study consisted of 203 cases 
and 461 controls. Of these, 181 cases (89.2%) and 408 controls (88.5%) agreed to 
participate. The numbers of first-degree relatives generated by these probands were 
1095 and 2346, respectively. Six subjects were excluded because they matched the 
exclusion criteria. In total, 1090 case relatives and 2345 control relatives entered the 
analysis.
Tables 2.1 and 2.2 present the distribution of demographic and clinical characteristics 
among probands and their relatives. Controls probands were, on average, 2.6 years 
younger and were more often female, while case probands more often had myopia and 
had undergone cataract extraction at a higher frequency. First-degree relatives were 
similar in most characteristics except the following: the mean age was significantly 
lower in relatives of controls, and myopia was significantly more often reported in 
relatives of cases.
Table 2.1 General characteristics of probands
Case 
probands
(n=181)
Control 
probands
(n=408)
P*
Age Mean (SD) 58.6 (15.3) 56.0 (14.0) 0.045
Age group <50 yrs (%) 40 (22) 142 (35)
50-70 yrs (%) 103 (57) 190 (47)
>70 yrs (%) 38 (21) 76 (19)
Sex Male (%) 118 (65) 172 (42) <0.001
Female (%) 63 (35) 236 (58)
Family size Mean (SD) 6.0 (3.6) 5.8 (3.4) 0.31
No. of siblings Mean (SD) 4.1 (2.9) 3.9 (2.7) 0.51
No. of offspring Mean (SD) 2.0 (1.7) 1.9 (1.4) 0.90
Myopia Number (%) 116 (64) 136 (13) <0.001
Surgery Lensectomy (%) 43 (24) 20 (4.9) <0.001
Vitrectomy (%) 2 (1.2) 1 (0.2) 0.18
Glaucoma (%) 0 2 (0.5) 0.61
Strabismus (%) 3 (1.7) 4 (1.0) 0.23
* adjusted for age and sex where appropriate
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Risk of RRD for first degree relatives
Retinal detachments in relatives were initially reported by 13 case probands and 15 
control probands. Validation of the diagnosis of RRD by medical reports reduced the 
numbers to 13 relatives of 10 case probands and 9 relatives of 8 control probands. 
Misclassification of the reported RRD was caused by confusion with a large range of 
other ophthalmic pathology, varying from cataract extraction to removal of epiretinal 
membranes.
The relative group that showed a significant higher absolute RRD frequency between 
cases and controls was the sibling group (n=12 [1.6%] versus n=7 [0.4%]; P=0.01); 
there was no statistically significant difference in absolute RRD frequency in offspring. 
A summary of the number of all affected first-degree relatives per proband is given in 
Table 2.3. Table 2.4 presents the frequency distribution and the risk of RRD for first-
degree relatives. The annual incidence of RRD in relatives of cases was estimated at 
23.9 per 100,000 individuals, and in relatives of controls 8.24 per 100,000.
Table 2.3 Frequencies of rhegmatogenous retinal detachment in siblings and offspring per 
proband
Total 
number 
of 
affected
Case probands (n=181) Control probands (n=408) 
No. (%)
No. with 
affected 
siblings 
No. with 
affected 
offspring
No. (%)
No. with 
affected 
siblings 
No. with 
affected 
offspring
0 171 
(94.4)
0 0 400 
(98.1)
0 0
1 8 (4.4) 7 1 7 (1.7) 5 2
2 1 (0.6) 1 0 1 (0.2) 1 0
3 1 (0.6) 1 0 0 0 0
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Bilaterality of RRD was present in one (8%) of 13 affected relatives of cases. The 
interval between the RRDs was 2 years. In controls, none of the nine affected relatives 
had a bilateral RRD. Retinal breaks without retinal detachment in fellow eyes were 
found in another two relatives of cases (15.4%), and in only one relative of controls 
(11.1%). These breaks were round atrophic holes in both case relatives, and a cribrous 
area in the control relative. All were seen within 2 years of the event. One patient from 
the case group had undergone laser treatment.
Figure 2.1 shows the cumulative lifetime risk of all types of RRD as a function of age 
for the total group of siblings and offspring. Relatives of cases had a higher frequency 
of RRD. Beyond 50 years, an increasing discrepancy was found between the two 
groups. Not only did the risk of RRD appear higher for relatives of cases, the curve 
had also shifted to the left, implying an earlier onset of RRD among case families. 
However, before the age of 69 years there was no statistically significant difference. 
The lifetime absolute risk at age 85 years for case relatives was 7.7% and for control 
relatives, 3.0%. This resulted in a risk ratio of 2.6 (95% confidence interval, 1.1-6.2).
Case and control probands with myopia had more affected relatives than probands 
without myopia. Of all 1333 relatives derived from case and control probands with 
myopia, 1.13% were diagnosed with RRD versus 0.33% of 2102 relatives of probands 
without myopia. This resulted in an age- and sex-adjusted odds ratio of 4.04 (95% 
confidence interval, 1.64-9.96). The frequency difference of relatives with RRD 
0
1
2
3
4
5
6
7
8
9
0 20 40 60 80 100
Age (yrs)
C
um
ul
at
iv
e 
lif
et
im
e 
ris
k 
(%
) Relatives of cases
Relatives of controls
Figure 2.1 Cumulative lifetime risk of all types of rhegmatogenous retinal detachment as a 
function of age for siblings and offspring of cases versus siblings and offspring of controls
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between probands with and without myopia was more prominent in the case group: 
1.79% versus 0.46% (P=0.04) in the case group and 0.56% versus 0.31% (P=0.47) 
in the control group. Moreover, there was a significantly higher frequency of RRD in 
relatives of case probands with myopia versus control probands with myopia (1.8% vs. 
0.6%); P=0.03, suggesting interaction between myopia and proband status. However, 
the interaction term (myopia * proband status) did not reach statistical significance 
when added to the model in Table 2.4 (P=0.60).
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2.5 Comment
Our data show the presence of familial predisposition to nonsyndromic RRD. 
Siblings of subjects with this type of RRD had a threefold increased frequency of 
RRD compared with siblings of nonaffected subjects. This familial risk was not fully 
explained by the aggregation of known risk factors myopia, age and sex.
Our study was designed to compare the risks for RRD between affected relatives 
of unselected, consecutive RRD patients and healthy controls derived from the 
same district in the Netherlands. We limited our family data collection to siblings 
and offspring to enhance the reliability of clinical history. The data collection was 
performed in an identical fashion among both study groups. All histories of RRD 
were verified using medical records and the general diagnostic criteria of good 
clinical practice were applied. For probands we used stringent criteria and accepted 
only spontaneous nonsyndromic RRD, whereas for relatives we registered all types of 
RRD to examine the entire disease spectrum.
A limitation in our study is the low frequency of the disorder. We investigated a large 
population of relatives, but the number of outcome events was still small among both 
study groups. This limited the power of the analyses, although we were able to detect 
significant differences between groups. Another potential drawback was the reliance 
on family history for ascertainment of RRD. We do not think that this has distorted 
our results, because RRD appears to be a significant ophthalmologic event that has a 
great and memorable impact on patients and their families. In addition, the intensive 
validation procedure by medical records and adjudication by retinal specialists 
facilitated the diagnosis of genuine nonsyndromic RRD. Frequencies of reported RRD 
among the relatives were comparable with former reports.28;29 The annual incidence 
of RRD of 8.24 per 100,000 individuals in our control group was comparable with 
the annual incidences mentioned in British epidemiologic studies: 6.3 to 13.0 per 
100,000 subjects.30 Bilaterality of familial RRD appeared to be lower than the 15% 
to 25% in other family reports.28;31 The low frequency of retinal breaks and treatment 
in the second eye suggested that this could not be explained by higher awareness and 
preventative treatment. These other reports possibly harbour more high-risk families.
Myopia was an important risk factor for RRD in our study. Although a negative 
refractive error appeared to enhance the risk of RRD among relatives of both proband 
groups, the risk was higher for families of case probands. Former reports regarding 
familial nonsyndromic RRD predominantly describe myopic families.18;23;24;28;32 The 
genetic background of myopia is still unclear, but linkage in specific families has been 
found with five different loci (Xq28; 18p11.31; 12q21-q23; 7q36; 17q21-q22).19;33-36 
Cataract extractions did not precede RRD considerably more frequent in relatives of 
cases than in relatives of controls, indicating that cataract extraction did not explain 
familial aggregation of RRD in our study.
Our data suggest that genetic risk factors for RRD, other than those determining axial 
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length, exist, because myopia did not fully explain the increased risk in first-degree 
relatives in our study. Moreover, our data implying interaction between myopia and 
proband status may indicate that myopia genes have influence on these other genetic 
determinants. Additional support for the existence of genes not involving myopia 
comes from former family reports that describe autosomal dominant occurrence 
of spontaneous nonsyndromic RRD without myopia.24-26 In a previous report, we 
presented evidence for linkage with the region containing the COL2A1 gene in two 
unrelated RRD families, and identification of the pathogenic mutation in one family. 
COL2A1 codes for the three α1-chains of collagen type II and for the precursor of the 
α3-chain of collagen type XI, a collagen that forms the core of collagen type II.37;38 
This collagen is important for the structure of the vitreous and maintenance of the 
vitreoretinal interface, and it is likely that dysfunction increases the risk of RRD. 
Other genes serving similar functions may exist.
Do RRD families require specific clinical care? The current policy for treatment is 
described in the American Academy of Ophthalmology Preferred Practice Pattern.39 It 
does not offer specific guidance in clinical management of relatives of patients with 
RRD. Our demonstration of familial aggregation of RRD suggests that these patients 
require extra awareness of prodromal symptoms. Further investigation is needed to 
decide if preventative treatment for retinal detachment should be performed at an 
earlier stage in these relatives, especially in those with myopia.
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3.1 Abstract
Purpose:
To study the clinical appearance and surgical results of autosomal dominantly 
inherited, rhegmatogenous retinal detachments (RRDs).
Methods:
After prospective examination of all but two family members, the medical records of 
16 affected patients (21 eyes) of two families from the Netherlands with autosomal 
dominantly inherited RRD were retrospectively evaluated. Special attention was paid 
to the age at onset, the ocular morphology and the clinical appearance of the RRD. 
The type and number of the various surgical procedures were analyzed with respect to 
preoperative appearance of the RRD, postoperative results and final visual acuity.
Results:
The mean age at onset of RRD of affected individuals in family A and B was 37±18 
years and 19±10 years, respectively. The mean ocular axial length in the two families 
was 24.7 mm and 26.7 mm. The mean number of retinal defects preoperatively found 
was 2.2 in family A and 7.1 in family B. Round, atrophic retinal holes predominated. 
Two of 21 affected eyes showed significant preoperative proliferative vitreoretinopathy. 
Pars plana vitrectomy was the primary procedure in four cases; extra ocular buckling 
was the initial procedure in 15 cases. One eye received scleral folding with diathermy 
as primary surgery. Redetachment following surgery occurred in 5 of 10 cases in 
family A and 4 of 10 eyes in family B. Anatomical success could be achieved in 9 of 
10 and 8 of 10 eyes in family A and B, respectively. 
Conclusions:
In these families the prevalence of RRD is high. Most patients were affected at a 
relatively young age compared with non-genetically linked forms of RRD. Because 
of the low success rate of surgical intervention and, subsequently, the high number 
of operations necessary to achieve reattachment of the retina, the use of diagnostic 
genetic techniques to identify individuals at risk would be advisable. In these subjects 
measures to prevent RRD are an option, even when anatomical substrates of precursors 
of RRD are absent.
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3.2 Introduction
Rhegmatogenous retinal detachment (RRD) is a potential disastrous ocular disease 
which is defined as a separation of the neurosensory retina from the retinal pigment 
epithelium caused by a retinal break. The incidence of RRD is about 10 per 100,000 
population per year.1;2  If left untreated, the majority of cases of RRD will progress to 
complete detachment and result in blindness. Surgical intervention results in primary 
reattachment of the retina in about 76-85% of the cases. Overall, the success rate of 
surgery, defined in anatomical and not functional terms, is approximately 90-95%.3;4
The clinical appearance of RRD of presumed autosomal dominant origin has been 
reported.5;6 However, most of the patients described demonstrate additional ocular 
or systemic abnormalities, suggesting an underlying syndrome. An association with 
RRD is well known in autosomal dominant inherited disorders such as Stickler and 
Jansen syndrome, as well as in Wagner disease.7;8 In contrast to Wagner disease, the 
frequency of RRD in Jansen and in Stickler syndrome is significantly higher. In all 
of these syndromic disorders specific ocular and systemic abnormalities form typical 
phenotypes.8-12 Moreover, a number of connective tissue disorders associated with 
vitreoretinal degenerations and RRD have been reported, e.g., Kniest dysplasia, 
osteogenesis imperfecta, spondyloepiphyseal dysplasia congenita and Ehlers-Danlos 
syndrome.13-16
Surgery of RRD associated with syndromic ocular disorders such as Stickler syndrome 
and Wagner disease is frequently disappointing, and recurrence of RRD is common.7;11 
However, there is little information about the results of surgery in nonsyndromic 
forms of inherited RRD.
In this study we report the clinical characteristics and surgical outcome of affected 
members of two families with autosomal dominantly inherited RRD. In neither family 
were the classic ocular and systemic features of complex hereditary vitreoretinopathies 
such as Wagner disease and Stickler syndrome recorded, as described elsewhere.17
Our study was set out to establish whether the surgical outcome of patients suffering 
from nonsyndromic autosomal dominant RRD is as poor as the results of surgery in 
syndromic RRD reported in the literature.
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3.3 Patients and Methods
Our study was designed as a cross-sectional study, including (a) a prospective clinical 
investigation of affected and unaffected members of two families with autosomal 
dominantly inherited RRD and (b) a retrospective study of the clinical appearance 
and surgical results of RRD in affected family members.
We studied two unrelated families from the Netherlands (families A and B) with 
autosomal dominantly inherited RRD. DNA linkage analysis in all family members 
had shown that the RRD phenotype in both families cosegregated with the 12q13 
region containing the COL2A1 gene. In family A no mutation could be identified in 
the protein coding exons of COL2A1; in family B, an Arg435Ter mutation located in 
the triple helical domain of the COL2A1 gene was found.17
The study was divided into two parts. The first part comprised a prospective 
investigation including affected and nonaffected members of both families. All 29 
members of family A and in 40 members of family B were questioned in detail as to 
their medical history, focusing on ophthalmic, audiologic, cardiologic and orthopaedic 
aspects, to exclude the presence of an underlying syndrome. In two members of 
family B, such an interview was not possible. The eyes of all other subjects were 
prospectively examined by two experienced investigators (SLG and CBH) and 
underwent extensive inspection by binocular contact lens biomicroscopy and slit-
lamp microscopy in order to exclude features of syndromic ocular diseases. We paid 
particular attention to cataract formation, vitreous degenerations and membranes, 
and specific retinal changes. If possible, the axial lengths of the eyes were recorded 
with applanation ultrasound biometry (Ocuscan; Alcon, Irvine, CA, USA). General 
physical examination was performed to detect possible abnormalities of the palate, 
face, joints and heart sounds. In affected individuals who were willing to cooperate, 
audiometry was carried out (6 members of family A and 10 members of family B).
In the second part of our study we retrospectively evaluated the medical records of 
the 16 affected individuals (21 eyes) of these two families. All patients with RRD 
had undergone vitreoretinal surgery in our department. The records of these patients 
were reviewed for preoperative, operative and postoperative data. Proliferative 
vitreoretinopathy (PVR) was classified according to the updated classification 
published in 1991 by the Retina Society.18 Due to the long period of time over which 
these patients presented, a number of different vitreoretinal surgeons were involved 
and various surgical techniques were used. All surgeons involved were experienced 
and based their diagnoses and surgical decisions on up-to-date literature. Moreover, 
all surgeons were familiar with the features of the syndromic disorders mentioned 
above.
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3.4 Results
The pedigrees of family A and B are depicted in Figures 3.1 and 3.2. Only 1 of 21 
affected eyes showed a juvenile cataract (individual BII-10). However, none of the 
remaining family members showed classic ocular or systemic features associated with 
Wagner disease, Stickler syndrome or other connective tissue disorders that might be 
associated with RRD, as detailed elsewhere.17 We found lattice degeneration in some 
family members, but not in any subject with RRD.
At the point of retrospective analysis the mean duration of follow-up of affected 
individuals was 7 years (range 1-9 years). The average age of onset of RRD in affected 
patients was 37 years (range 15-64 years) in family A and 19 years (range 6 to 35 
years) in family B. RRD of the fellow eye occurred in 3 of 8 patients in family A and 
in 2 of 8 patients in family B.
The number of preoperatively localized retinal defects was 2.2 (range 0-7) in family 
A and 7.1 (range 1-28) in family B. Details of localization, type and size of retinal 
holes are listed in Table 3.1. Five cases in family A and two cases in family B had 
minimal preoperative PVR (grade A). In Family A, we found two eyes with serious 
PVR before first surgery. Further details concerning PVR are given in Table 3.1.
Figure 3.1 Pedigree of family A, showing an autosomal dominant mode of inheritance of 
rhegmatogenous retinal detachments
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In both families, we observed moderate to high myopia with an average ocular axis 
length of 24.7 mm (range 20.2 mm to 28.2 mm) in family A and 26.7 mm (range 25.4 
mm to 28.7 mm) in family B.
The mean number of operations was 2.4 (range 1-6) in family A and 2.5 (range 1-8) 
in family B. Eventually, the retina remained detached in two patients of family A and 
in one patient of family B. Surgical failure after the initial procedure was attributed to 
PVR in four of five cases in family A and in three of four cases in family B. Surgical 
data are listed in detail in Table 3.1. The average final visual acuity was 20/80 (range 
20/20 to no light perception) in family A and 20/50 (range 20/25 to no light perception) 
in family B. In 3 of 10 treated eyes in family A and in 3 of 10 operated eyes in family 
B, final visual acuity was hand motions or worse. For further details see Table 3.1.
III
Family B
I
II
1 2 3 4 5 6 7 8 10 11 14 15 17 18 19
1 2
9 12 13 16
*
*
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Unaffected
Not
examined
Retinal breaks
RRD
* Bilateral RRD
Figure 3.2 Pedigree of family B, showing an autosomal dominant mode of inheritance of 
rhegmatogenous retinal detachments
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3.5 Discussion
Autosomal dominantly inherited vitreoretinal disorders frequently lead to RRD, and in 
such cases the outcome of surgery has been reported as poor.7;15;16 To our knowledge, 
there have been no reports about surgery of inherited RRD unassociated with other 
ocular or systemic disorders.
In both of the families in our study, the underlying genetic defect was located in the 
chromosomal region containing the COL2A1 gene, and in one of the families (family 
B), a protein-truncating mutation was found in the middle of the helical domain of 
the COL2A1 gene, a type of mutation generally found in patients with classic Stickler 
syndrome.17 To date, there is no clear explanation for this finding. In a family as large 
as family B it is remarkable that not a single patient showed the features of classic 
Stickler syndrome. Although an atypical ocular form of Stickler syndrome cannot 
be excluded, predominantly ocular Stickler syndromes have been associated with 
COL2A1 exon 2 mutations.19 In contrast, the genetic defect found in family B was an 
exon 30 mutation.17
At presentation, the majority of the patients reported in our study were relative young. 
Especially in family B the average age of 18 years was strikingly low. In contrast, 
the mean age of patients with sporadic RRD is about 60 years.20;21 Interestingly, RRD 
in our patients was predominantly caused by a high number of round, atrophic holes 
rather than by characteristic horseshoe tears, which are typical for sporadic RRD. Our 
findings concerning retinal defects correlate with those observed in RRD patients with 
high myopia, Kniest dysplasia and Stickler syndrome.7;15;22
In our group of patients a marked number of bilateral RRDs occurred. Three of eight 
patients in family A and two of eight patients in family B, e.g. almost one third of all 
RRD patients, were bilaterally affected. This significantly increased risk for the fellow 
eye is not so obvious in sporadic cases, where bilaterality occurs in about 4,2-19% of 
those affected.1;2;20;22 
Both the young age of our patients and the fact the RRDs seem to be caused by small 
atrophic holes rather than horseshoe tears suggest that an intrinsic fragility of the 
retina rather than traction at the vitreoretinal interface is responsible for this disorder. 
Although none of the affected subjects in our study demonstrated any symptoms that 
can be assumed to be part of a syndromic disease, the poor outcome of RRD surgery 
in our patients corresponds with the equally disappointing results in RRDs associated 
with Stickler syndrome.7 This unfortunate surgical prognosis is in contradiction to the 
outcome of surgery in sporadic, nonsyndromic RRD.3;4
The poor surgical results in our patients were independent of the surgical technique 
used. Moreover, the surgical outcome in recently treated patients from our families 
was not better than the results in family members operated on more than 20 years 
ago. Thus, individuals suffering from autosomal dominantly inherited RRD may not 
benefit from the recent advances in vitreoretinal surgical techniques.
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Due to the poor surgical success rates timely identification of subjects at risk is 
desirable in order to prevent the manifestation of RRD. Moreover, genetic evaluation 
could identify even very young individuals at risk.
Although asymptomatic retinal defects in phakic eyes did not significantly increase 
the risk for sporadic RRD in long-term observation23, prophylactic treatment of 
defects has been advised for patients with Stickler syndrome and other vitreoretinal 
hereditary diseases.24 Consequently, we propose prophylactic laser treatment of 
genetically affected family members with retinal defects, which should cover the entire 
360° because of the speculated intrinsic fragility of the retinal periphery. However, 
retinopexy should be carried out very gently in view of the reported posterior vitreous 
detachment after prophylactic laser treatment in inherited RRD7 and because of the 
high prevalence of PVR in our patients. To date, we have not been able to identify 
genetically affected subjects who were asymptomatic. Therefore, the benefit of 
prophylactic treatment in those family members is only speculative.
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4.1 Abstract
Purpose:
To investigate the clinical features and molecular causes of autosomal dominant 
rhegmatogenous retinal detachment (RRD) in two large families.
Methods:
Clinical examination and linkage analysis of both families using markers flanking 
the COL2A1 gene associated with Stickler syndrome type 1, the loci for Wagner 
disease/erosive vitreoretinopathy (5q14.3), high myopia (18p11.31 and 12q21-q23), 
and nonsyndromic congenital retinal nonattachment (10q21).
Results:
Fifteen individuals from family A and 12 individuals from family B showed RRD 
or retinal tears with minimal (family A) or no (family B) systemic characteristics of 
Stickler syndrome and no ocular features of Wagner disease or erosive vitreoretinopathy. 
The RRD cosegregated fully with a chromosomal region harbouring the COL2A1 
gene with maximum lod scores of 6.09 (family A) and 4.97 (family B). In family 
B, an Arg453Ter mutation was identified in exon 30 of the COL2A1 gene, that was 
previously described in a patient with classic Stickler syndrome. In family A, DNA 
sequence analysis revealed no mutation in the coding region and at the splice sites of 
the COL2A1 gene.
Conclusions:
In two large families with RRD, linkage was found at the COL2A1 locus. In one of 
these families an Arg453Ter mutation was identified, which is surprising, because all 
predominantly ocular Stickler syndrome cases until now have been associated with 
protein-truncating mutations in exon 2, an exon subject to alternative splicing. In 
contrast, the Arg453Ter mutation and other protein-truncating mutations in the helical 
domain of COL2A1 until now have been associated with classic Stickler syndrome.
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4.2 Introduction
Rhegmatogenous retinal detachment (RRD) often is associated with (pathologic) 
myopia and in most cases leads to visual impairment or blindness if untreated.1;2 
Early diagnosis of RRD and recognition of patients at risk improve the prognosis 
(see Reference 3 and the references therein). Nonsyndromic pathologic myopia (-6 
D or less) in most cases occurs sporadically, but is also encountered as an autosomal 
dominant or X-linked trait in families.4-7 RRD with autosomal dominant inheritance 
in association with myopia and vitreoretinal degeneration is usually described as a 
feature of Stickler syndrome or erosive vitreoretinopathy. RRD also has been reported 
in the original Wagner family, although less frequent.8
Stickler syndrome is characterized by systemic abnormalities as midfacial hypoplasia, 
midline cleft of the palate, sensorineural hearing loss, early progressive arthropathies, 
and hypermobility, in combination with ocular abnormalities, such as high myopia, 
abnormalities of the vitreous structure, paravascular pigmentation and possibly giant 
tears causing retinal detachment.9-11 Mitral valve prolapse also has been reported.12 
These features show intra- and interfamilial variability of expression. Moreover, 
different types of Stickler syndrome can be distinguished based on the presence or 
absence of ocular abnormalities, the appearance of the vitreous, and the molecular 
genetic findings. Type 1 Stickler syndrome is characterized by a membranous vitreous 
phenotype and is caused by mutations in the COL2A1 gene.13-15 Type 2 Stickler syndrome 
exhibits a different beaded vitreous phenotype and has been associated with COL11A1 
mutations.15-17 Nonocular Stickler syndrome type 3, with a phenotype displaying 
characteristic systemic abnormalities such as facial abnormalities, cleft palate, hearing 
loss, and arthropathies, but without high myopia, vitreoretinal degeneration, or retinal 
detachments, is caused by mutations in COL11A2.18-20 Evidence of at least a fourth 
locus for Stickler syndrome has been found, as mutations in the former three known 
genes were not found in some Stickler families.17;21
Wagner disease, on the other hand, is a nonsystemic disorder in which the vitreous is 
optically empty, and a preretinal membrane is present in the periphery of the retina, 
sometimes only as a thin white circular line. A progressive complicated cataract 
appears in most of the patients, chorioretinal atrophy, peripheral pigment foci, and a 
situs inversus of the optic disc may be present.22-24 Wagner disease has been mapped 
to the long arm of chromosome 5 in region 14.3 (5q14.3).25
In erosive vitreoretinopathy, progressive thinning of the retinal pigment epithelium 
resulting in severe degeneration is the major feature. In addition, and in contrast with 
Wagner disease, a pronounced roped and veiled syneresis of the vitreous body with 
traction at lesions of the retinal pigment epithelium and frequent development of 
retinal detachment, both rhegmatogenous and tractional, are observed. As in Wagner 
disease, no systemic abnormalities are found.26;27 The disorder maps to the same region 
as Wagner disease, 5q13-q1427, suggesting that erosive vitreoretinopathy and Wagner 
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disease may be allelic disorders.
In this report, we present two large families with autosomal dominant RRD or retinal 
breaks without or with minimal systemic features, clinically different from Wagner 
disease, erosive vitreoretinopathy, and typical Stickler syndrome. Both families 
showed linkage to a genomic region containing the COL2A1 gene. In one of the 
families, a stop codon mutation was found in the helical domain of the COL2A1 gene 
that had been found earlier in a patient with typical Stickler syndrome.
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4.3 Patients and methods
Two unrelated Dutch families of white origin with autosomal dominant RRD were 
studied. Family A consisted of 28 individuals; family B consisted of 22 individuals 
(Figure 4.1). The study protocol followed the tenets of the Declaration of Helsinki, 
and informed consent was obtained from each participant or their guardians, after 
general approval by the Ethics Committee of the University Medical Centre Nijmegen, 
the Netherlands.
Figure 4.1 Haplotype analysis of families with RRD or retinal breaks with markers encompassing 
the COL2A1 gene on the long arm of chromosome 12, region 13.11. (See next page)
The COL2A1 gene resides between markers D12S1701 and D12S1661. The shared alleles from 
the at-risk haplotype are shown in black bars, marker alleles between brackets are deduced. 
(A) Family A: the boundaries of the critical interval between D12S1631 and D12S1691 are 
determined by recombination events in affected individuals AIII-8, AIII-16 and AIV-2. (B) 
Family B: the critical interval between D12S1663 and D12S335 is determined by recombination 
events in affected individuals BII-15 and BIII-5. Note that marker D12S1691 in individuals 
BII-2 and BIII-4 are noninformative (grey bars). Assuming that individual BIII-6 is not a 
nonpenetrant, the telomeric boundary is demarcated by marker D12S1691, thereby reducing 
the critical region to 15.8 cM. The DNA marker order and distances were derived from the 
Human Genome Browser (April 2002 assembly)28 and Généthon.29 Note the overlap of the 
critical intervals of families A and B. 
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Clinical examination
An extensive clinical history of all individuals especially regarding ophthalmic, au-
diologic, cardiologic, and orthopaedic disorders, and current symptoms was recorded. 
Existing ophthalmic records of all participants and, if possible, of the deceased were 
collected and reviewed regarding age of onset of myopia, structure of the vitreous 
body, retinal breaks, retinal detachments or other abnormalities of the fundus, bio-
metric measurements, and intraocular pressure. Clinical examination included best 
corrected visual acuity, slit-lamp microscopy, applanation tonography, fundoscopy in-
cluding fundus photography, and Goldmann three-mirror contact glass examination. 
These examinations were performed in 27 individuals in family A and 22 individuals 
in family B by both a highly experienced medical retina specialist (CBH) and by the 
first author (SLG). Special attention was paid to the vitreous body structure. Axial 
length measurement and keratometry were performed, using ultrasound. In cases of 
axial length of 25 mm or longer or in cases with closed pupillae, ultrasound examina-
tion of the posterior eye was performed. All individuals with retinal detachments or 
retinal breaks were considered affected.
Physical examination including assessment of facial, palatal, joint, and heartsound 
abnormalities was prospectively performed in affected individuals who were willing 
to cooperate. Existing audiologic, cardiologic, and orthopaedic medical records were 
collected. Facial and palatal photographs were taken. The Beighton score for hyper-
mobility of joints30 and audiometry were assessed in six cases of family A and ten of 
family B.
Molecular genetic analysis
DNA was extracted from leucocytes from 10 mL of peripheral blood of all individuals, 
according to a protocol adapted from Miller et al.31 Linkage analysis was performed 
with radioactively labelled microsatellite markers. The candidate loci were the two 
loci for autosomal dominant high myopia on chromosome 18p11.31 (MYP2; markers 
D18S52 [AFM020tf12] and D18S1154 [AFMa056ye1]) and 12q21-q23 (MYP3; 
markers D12S64 [MFd155a], D12S82 [AFM107xc11] and D12S317 [AFM065ye9]), 
the Wagner disease/erosive vitreoretinopathy locus on 5q14.3 (markers D5S428 
[AFM238xf4] and D5S2094 [AFMa055td9]), the locus for nonsyndromic congenital 
retinal nonattachment on 10q21 (marker D10S581 [AFM287yf9]), and the genes for 
Stickler syndrome COL2A1 on 12q13.11-q13.2 and COL11A1 on 1p21.1. For COL2A1, 
residing between markers D12S1701 and D12S1661, we used the following markers 
(from pter to qter; genetic distances indicated): D12S1631 (AFMa288wd5) -5.8 
centimorgans (cM)- D12S1663 (AFMb316xd9) -6.2 cM- D12S1701 (AFM345xf1) 
-1.4 cM- D12S1661 (AFMb314yh5) -4.6 cM- D12S1618 (AFMa224yg1) -3.6 cM- 
D12S1691 (AFM312xf5) -5.3 cM- D12S335 (AFM273vg9).29 No marker near 
COL11A1 was tested, because linkage was found at the COL2A1 locus. DNA samples 
were subjected to polymerase chain reaction (PCR) amplification with a standard 
cycling profile of 30 cycles at 94oC, 55oC, and 72oC with 1, 2, and 1 minute(s) 
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respectively at each step. DNA markers were labelled by the incorporation of α[32P]-
dCTP and the products were separated by electrophoresis on a 6.6% denaturing 
polyacrylamide gel.
Linkage analysis by calculating two-point lod scores was performed using the 
MLINK routine from the LINKAGE (Version 5.1) software suite.32-34 Lod scores in 
both families were calculated with a presumed penetrance rate of 95% and an allele 
frequency of 0.001.
Mutation analysis of the COL2A1 gene was performed by direct sequencing (BigDye 
Terminator on a Prism 377; Applied Biosystems, Foster City, CA USA). The entire 
coding region of the gene, comprising 54 exons, was amplified in 38 amplicons. 
Primer pairs and conditions are available on request. To ascertain mutations that could 
affect the splicing, at least 42 bps (average 104 bps) of the flanking intronic sequences 
were amplified. Twenty-one introns (introns 3-6, 9, 13, 20, 21, 24, 25, 30, 32, 35, 40, 
42-48) were entirely amplified. Sequence analysis was performed on both strands of 
each amplicon using both forward and reverse primers.
To assess the stability of the mutant COL2A1 messenger RNA (mRNA), Epstein-Barr 
virus- transformed lymphoblastoid cell lines were established from heparin blood of 
two affected individuals from family B. Before RNA extraction, half of the cultured 
cells were incubated for 4 hours with 100 µg/mL cycloheximide. In cells grown with 
cycloheximide, a protein synthesis inhibitor, the nonsense-mediated mRNA decay 
process is prevented.35 After RNA extraction and reverse transcription-PCR (RT-
PCR), a fragment of the cDNA encompassing the mutation in exon 30 was amplified 
using a first set of primers, 5051F (5`-tgcctggtgaaagaggacggac-3`) and 5054R (5`-
ggcattccctgaagacctggag-3`), followed by a nested PCR and direct sequencing of the 
band of interest with primer 5053F (5`- tcaagatggtctggcaggtccc-3`) and the same 
reverse primer 5054R.
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4.4 Results
Clinical examination
The ophthalmic examination was performed in 27 of 28 individuals from family A 
and in all 22 individuals from family B. One individual (AIII-3) refused prospective 
clinical examination, but could be considered affected because a retinal break was 
described in his medical files. Medical files of AI-2 and AII-1 were not available, but 
these family members were determined by hearsay to be affected. The medical files 
of individual BI-1 showed a retinal break and that person was thus considered to be 
affected. BI-2 had no known health problems before her death. The clinical features of 
all affected individuals (15 of 28 in family A, 12 of 22 in family B) and the available 
information about BI-1 are shown in Table 4.1. Refractive error comprised the whole 
scale of mild hypermetropia to high myopia in family A, whereas the scale was limited 
between no myopia and severe myopia in family B, with a tendency toward moderate 
or high myopia. In both families, the myopia was axial-length dependent (mean axial 
lengths: 24.8 mm [range 20.2-28.2 mm] in family A, 26.6 mm [range 24.9-28.7 mm] 
in family B). There was no specific abnormality of the vitreous body that was found 
in all affected individuals in both families, especially no consistent vitreal membranes 
or beaded strands. Only RRDs, or at least retinal breaks, were a consistent ophthalmic 
finding throughout the families. In family A, 11 RRDs occurred in 8 of the 15 affected 
family members, with an average age of first onset of RRD of 36 years (range 16-64 
years). Seven of the 12 affected members of family B experienced early RRDs in nine 
eyes. The average age of onset of RRD in this family was 14 years (range 7-22 years). 
Eyes with RRDs showed a tendency to multiple (average 2; range 0-7) peripheral 
holes or horseshoe tears in the temporal superior and inferior quadrants in family 
A, whereas the periphery of the eyes of the affected in family B mostly revealed 
round multiple (average 8; range 1-28) retinal holes in the temporal superior quadrant. 
Bilateral RRDs were seen in patients AIII-5, AIII-18, AIV-2, BII-2 and BIII-4.
The history and clinical examination of all examined individuals of both families 
revealed no systemic abnormalities, except for five persons. Individual AII-6 had a 
history of surgery for a left-side cerebellar cyst and showed a sensorineural hearing 
defect in all frequencies of the left ear only. Thresholds at frequencies 0.25, 0.5, 1, 2, 
4 and 8 kHz (thresholds more than age-related between brackets), respectively, were 
[50], 20, [50], [70], [100] and [110] dB hearing loss at the age of 76 years. AIII-2, 
at 54 years of age, had a slightly recessed chin, a symptomatic progressive low- and 
midfrequency sensorineural hearing loss with thresholds of [25], [42.5], [55], [50], 
32.5 and 40 dB, respectively, for both ears (ADS), and symptoms of occasionally stiff 
fingers of both hands and pains in her left knee after long walks. AIII-5 had thresholds 
of 15, 17.5, [25], [30], 30 and [67.5] dB hearing loss ADS, but was asymptomatic 
at 53 years. AIII-6 had a noise-exposition history and at the age of 51 years showed 
thresholds of 12.5, 17.5, 5, 7.5, [50] and 7.5 dB hearing loss ADS. Finally, individual 
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BIII-4 had a transient flat nose bridge in the first decade of his life, but now has a 
normal facial appearance. Individuals BII-15 and BIII-3 showed a small air bone gap 
of 7 dB, probably related to tubal dysfunction at the time. As was true of all other 
patients from this family, they had a normal symmetrical age-related sensorineural 
threshold.
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DNA analysis
We excluded the involvement of the MYP2 and MYP3 loci for autosomal dominant 
high myopia, as well as the loci for Wagner/erosive vitreoretinopathy and nonsyndromic 
congenital retinal nonattachment by linkage analysis in family A (Table 4.2).
Table 4.2 Lodscores for Two-Point Linkage analysis in RRD families A and B
Family A
Locus Location Marker Recombination fraction
0.000 0.010 0.050 0.100 0.200 0.300 0.400 0.500
MYP2 18p11.31 D18S52 -11.13 -6.00 -3.16 -1.85 -0.69 -0.22 -0.04 0.00
D18S1154 -12.01 -7.29 -3.71 -2.03 -0.60 -0.07 0.07 0.00
MYP3 12q21-q23 D12S64 -4.04 -1.17 -0.11 0.35 0.56 0.40 0.14 0.00
D12S82 -∞ -10.43 -6.67 -4.54 -2.16 -0.93 -0.29 0.00
D12S317 -8.31 -4.88 -3.01 -1.78 -0.62 -0.17 -0.03 0.00
WGN1/
ERVR
5q14.3 D5S428 -9.18 -5.21 -2.54 -1.32 -0.30 0.02 0.07 0.00
D5S2094 -8.31 -4.33 -2.42 -1.49 -0.63 -0.24 -0.05 0.00
NCRNA 10q21 D10S581 0.86 0.84 0.74 0.63 0.40 0.20 0.05 0.00
COL2A1 12q13.11-q13.2 D12S1631 -5.38 2.00 3.01 3.10 2.63 1.82 0.84 0.00
D12S1663 4.91 4.82 4.45 3.97 2.97 1.91 0.82 0.00
D12S1701 5.79 5.69 5.28 4.75 3.63 2.41 1.11 0.00
D12S1661 6.09 5.98 5.56 5.01 3.83 2.56 1.19 0.00
D12S1618 5.79 5.69 5.28 4.75 3.63 2.42 1.11 0.00
D12S1691 -0.81 1.55 2.30 2.46 2.17 1.53 0.69 0.00
Family B
Locus Location Marker Recombination fraction
0.000 0.010 0.050 0.100 0.200 0.300 0.400 0.500
COL2A1 12q13.11-q13.2 D12S1631 -3.23 1.67 2.28 2.37 2.03 1.39 0.54 0.00
D12S1663 -1.93 2.89 3.27 3.16 2.56 1.72 0.69 0.00
D12S1701 2.62 2.58 2.38 2.13 1.59 0.99 0.37 0.00
D12S1661 1.72 1.69 1.57 1.41 1.07 0.68 0.26 0.00
D12S1618 4.97 4.89 4.55 4.12 3.17 2.09 0.86 0.00
D12S1691 0.42 0.47 0.58 0.62 0.54 0.35 0.11 0.00
In both families, highly polymorphic DNA markers flanking the COL2A1 gene 
showed co-segregation with the disease (Table 4.2). In family A, the critical region 
is demarcated by markers D12S1631 and D12S1691 (interval: 21.6 cM, 28 Mb), 
based on crossovers observed in the affected individuals AIII-8, AIII-16 and AIV-2 
(Figure 4.1A). The maximum lod score, 6.09, was detected for marker D12S1661 at a 
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Figure 4.2 COL2A1 mutation analysis in patient BII-6
(A) DNA sequence analysis of part of exon 30 (previously denoted as exon 28) of the COL2A1 
gene. Top: sequence of a control individual; bottom: sequence of the clinically affected 
individual BII-6, carrying a heterozygous C-to-T transition resulting in an Arg453Ter mutation. 
(B) RNA analysis of the Arg453Ter mutation in patient BII-6. Top: sequence of the cDNA of 
the patient. Because of mRNA instability, the transcript of the mutant allele was not detectable. 
Bottom: sequence of the cDNA of the patient obtained after incubation of lymphoblastoid cells 
in a medium containing cycloheximide, which prevents nonsense-mediated mRNA decay. 
Sequence analysis shows presence of transcripts from both the normal and the mutant allele.
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recombination fraction (θ) of 0.0. In family B, a linked chromosomal region of 21.1 cM 
(26 Mb) was delimited by markers D12S1663 and D12S335, based on recombination 
events observed in affected individuals BII-15 and BIII-5 (Figure 4.1B). A maximal 
lod score of 4.97 was found for marker D12S1618 at θ = 0.0. Assuming that the 
healthy individual BIII-6 is not a nonpenetrant, the telomeric boundary is demarcated 
by marker D12S1691, thereby reducing the critical region to 15.8 cM (16 Mb).
In family A, analysis of all 54 exons and flanking intronic regions of COL2A1 failed to 
identify a mutation in the coding region or at the splicing sites of the gene.
In family B, mutation analysis of the COL2A1 gene showed a C-to-T transition in 
exon 30 (previously denoted as exon 28), resulting in a change of codon CGA of 
Arg 453 for a stop codon (Figure 4.2A). Ninety-six ethnically matched controls did 
not show this mutation. Analysis of RNA extracted from lymphoblastoid cells grown 
with and without cycloheximide from patient BII-6 showed stability of mutant RNA 
only in cells grown with cycloheximide (Figure 4.2B), strongly suggesting that the 
COL2A1 mRNA carrying the Arg453Ter mutation is unstable.
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4.5 Discussion
In this study, we report on a family (B) that shows autosomal dominant RRD 
associated with a mutation in the triple helical domain of the COL2A1 gene. The 
mutation, Arg453Ter, has been described in a sporadic patient with Stickler syndrome, 
who had had such classic features as cleft palate, midfacial hypoplasia, sensorineural 
hearing loss, joint laxity, and joint pains since the second decade, besides high myopia, 
vitreoretinal degeneration with a typical type I vitreous anomaly (William G. Cole, 
personal communication, 2002), retinal breaks, and retinal detachment in the first 
decade.36 Protein-truncating COL2A1 mutations are commonly found in patients with 
Stickler syndrome.
The phenotype observed in patients in family B however, was different from the 
classic Stickler syndrome. In all 12 RRD patients -even in the eldest generation- cleft 
palate, joint laxity, joint pains or sensorineural hearing loss were absent, whereas 
these symptoms were already present in the reported 23-year-old patient.36
Use of Snead’s criteria- that is, a congenital vitreous anomaly (type 1: membranous, 
or type 2: fibrillar, beaded) and any three of the following: (a) myopia with onset 
before 6 years of age, (b) RRD or paravascular pigmented lattice degeneration, (c) 
joint hypermobility with abnormal Beighton score, either with or without radiological 
evidence of joint degeneration, (d) audiometric confirmation of sensorineural hearing 
defect, and (e) midline clefts15 in this family also indicates that patients of family B are 
clinically different from patients with classic Stickler syndrome. First of all, except four 
patients in whom membranelike vitreous abnormalities were found (individuals BII-
4, BII-12, BIII-3 and BIII-4), no members of family B revealed a vitreous consistent 
with a type I or type II Stickler vitreous. In BII-4, the membranelike structure was 
absent 23 years later, possibly due to degeneration of the membrane.
Furthermore, myopia, if present, was not always present before 6 years of age (data not 
shown). Joint hypermobility with abnormal Beighton score and midline clefts were not 
observed, and were not anamnestically present during childhood. Audiometric results 
were not suggestive of Stickler syndrome, and in both BIII-3 and BII-15 were most 
probably due to tubal dysfunction at the time of examination. Moreover, although 
none of the affected individuals from family B had joint pains, according to surveys, 
70% of patients with Stickler syndrome have joint pains before 20 years of age.37
Family A, in which the underlying genetic defect also cosegregates with the COL2A1 
locus, although no mutation could be detected in the coding region and at the splice 
sites of the gene, also does not meet the classic criteria nor Snead’s criteria for Stickler 
syndrome. First, the vitreous of all family members does not comprise consistent 
membrane- or threadlike abnormalities, though a thin vitreous body was present in 
several family members. In addition, a whole range of refractive errors between mild 
hypermetropia and high myopia was found in all affected individuals. No cleft palates 
were found, and though sensorineural hearing loss was found in four individuals, 
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it was not typical of Stickler syndrome. Two of these hearing defects are explained 
by noise exposition (AIII-6) and a left-side cerebellar cyst that had been surgically 
removed (AII-6). AIII-5 had an asymptomatic mid- and high-frequency hearing loss 
of 10 dB more than age-related hearing loss and only one individual, AIII-2, had a 
symptomatic, progressive sensorineural hearing defect of 23 dB more than age-related 
hearing loss. However, the defect in this patient affected the low- and midfrequencies, 
although in patients with Stickler syndrome, the hearing impairment generally involves 
the high frequencies and shows no more progression than is associated with normal 
aging.11;38 Joint hypermobility was not present during childhood and was not observed 
in those who had been examined. Except in patient AIII-2 at 51 years of age and 
patient AIII-5 who had pains in the left hip region during unexpected hip movements 
at age 49 years, no joint pains were found in patients of family A. Radiography of 
patient AIII-5 showed a moderate arthrosis of and reduced joint space in her left hip 
at the age of 52 years.
Previously described families with predominantly ocular Stickler syndrome invariably 
showed a type I vitreous anomaly, and all had mild to moderate systemic abnormalities, 
be it that these were present in only about half of the examined family members.39 
Also, if we consider each of these families as one unit, the abnormalities found in 
one family altogether invariably led to a complete Stickler syndrome diagnosis by 
Snead’s criteria. This “family diagnosis” could not be made in each of our families, 
when taking into account all clinical abnormalities. There also was no consistent type 
I vitreous anomaly.
We think that patients of families A and B do not have Wagner disease, because 
strongly progressive juvenile cataract and inverted papilla, preretinal membranes or 
peripheral circular lines were not present. Moreover, of the 15 affected members of 
family A, only four showed an optically empty vitreous body and one had empty parts 
in the vitreous body, whereas in family B only 1 of 12 affected individuals showed an 
optically empty vitreous body. In contrast, this was invariably present in patients from 
the original Wagner family.22
In conclusion, our results suggest that the patients in families A and B had an atypical 
form of predominantly ocular Stickler syndrome with RRD as the main clinical 
feature.
An important difference between both families is that retinal breaks and detachments 
in family B occurred at younger ages, mostly in the second and third decades, whereas 
in family A they mostly appeared in the fourth and fifth decades and, in a few cases, 
even later (individuals AII-4, AII-6, AII-7 and AIII-6; Table 4.1). 
Until recently, it seemed that COL2A1 gene mutations could be associated with type 
1 vitreous, whereas COL11A1 gene mutations were responsible for type 2 vitreous. 
Discussion of the role of the vitreous types in predicting the mutated gene, however, 
was recently published.40;41 In fact, a Stickler family with a type I vitreous had linkage 
to COL11A140, whereas in two Stickler families with a type II vitreous, COL11A1 gene 
mutations were excluded.21 Earlier posterior vitreoretinal detachment was suggested 
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to have caused these phenotypes, because in two families conversion from vitreous 
phenotype 2 into 1 was observed.41 Our data also contradict the hypothesis that all 
COL2A1 mutations are associated with a type I vitreous.
The most interesting result of this study, however, is the identification of a COL2A1 
exon-30 protein-truncating mutation (Arg453Ter), previously identified in a 
patient with classic Stickler syndrome36, in a large family with an atypical form of 
predominantly ocular Stickler syndrome.
Collagen molecules are typically composed of three polypeptide chains (α-chains) 
that form a triple helix. A characteristic repetitive amino acid sequence, glycine-X-
Y, is important for maintaining this helical structure. Three identical α1(II) chains, 
encoded by the COL2A1 gene, constitute collagen II, the main collagen in cartilage 
and vitreous. Moreover, α1(II) chains participate in the formation of collagen V/XI in 
combination with α1(XI) and α2(XI) chains in the cartilage, and α1(XI) and α2(V) 
chains in the vitreous.42
The COL2A1 gene is involved in several autosomal dominant disorders.43 A variety of 
cartilage disorders, such as achondrogenesis, spondyloepiphyseal dysplasia and Kniest 
dysplasia, are caused by missense mutations in COL2A1, generally changing one of 
the glycine residues of the triple helical structure, or by small in-frame deletions.43 
All these mutations probably disrupt normal collagen II and collagen V/XI structure 
through a dominant negative mechanism.
On the contrary, all COL2A1 mutations described in patients with Stickler syndrome 
(References 35, 36 and references therein) with a few exceptions44;45 lead to a 
premature termination codon. Some authors demonstrated that mutant mRNAs in 
patients with Stickler syndrome undergo nonsense-mediated mRNA decay, resulting 
in COL2A1 haploinsufficiency.45;46 Haploinsufficiency of α1(II) chain molecules 
could affect collagen II production or, more likely, will disturb the stochiometry of 
V/XI collagen.
The discovery of premature termination mutations in exon 2 of the COL2A1 gene 
in all families with predominantly ocular Stickler syndrome39 led to the speculation 
that exon 2 null mutations merely give rise to ocular abnormalities, because exon 2 is 
subject to alternative splicing and is predominantly present in fetal and adult vitreous 
mRNA, but is absent in mature cartilage mRNA. However, this explanation cannot 
apply to our families. In fact, no mutations were found in exon 2 of the COL2A1 
gene in either family, whereas the Arg453Ter mutation in family B was located in the 
COL2A1 helical domain of the gene.
RNA analysis in a patient in family B suggests that, as in typical Stickler syndrome45;46, 
haploinsufficiency underlies the disease. Although clinical variability in Stickler 
syndrome is very high, this does not satisfactorily account for the absence of systemic 
features in as large a family as family B.
As clinical variability in Stickler syndrome can generically be attributed to modifier 
factors, an intriguing hypothesis in our case would be that a transacting modifier 
factor is located in the vicinity of the COL2A1 locus, and that a favourable modifier 
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allele cosegregates in family B with the Arg453Ter COL2A1 mutation, resulting in the 
relatively mild phenotype. However, it is worthwhile to note that family B belongs 
to a relatively closed religious community. It is therefore possible that, more broadly, 
individuals of this family share a common “favourable” genetic background, due to 
one or more traits, that can reside everywhere in the genome.
In family A no COL2A1 mutation was found in the coding sequence, at the splice 
sites, or in the 21 introns of the gene that have been entirely sequenced. Whether the 
disease in family A follows a mechanism similar to that in family B remains to be 
elucidated.
Chapter 4 - Autosomal dominant rhegmatogenous retinal detachment
97
4.6 Acknowledgments
The authors thank the patients for their kind cooperation, Hannie Kremer for her help 
with linkage studies, and Bellinda van den Helm, Saskia D. van der Velde-Visser, 
Albert.L. Aandekerk and Evert-Jan Steenbergen for expert technical assistance. 
These studies were supported by grants from the Landelijke Stichting voor Blinden 
en Slechtzienden (SLG), the Algemene Nederlandse Vereniging ter Voorkoming 
van Blindheid, the Stichting voor Ooglijders, the Gelderse Blindenvereniging, the 
Rotterdamse Vereniging Blindenbelangen, the Stichting Blindenhulp, the Stichting 
Haagsch Oogheelkundig Fonds, the Researchfonds Oogheelkunde, and the Foundation 
“De Drie Lichten” in the Netherlands (MAvD, AM).
Chapter 4 - Autosomal dominant rhegmatogenous retinal detachment
98
References
1. Risk factors for idiopathic rhegmatogenous retinal detachment. The Eye Disease 
Case-Control Study Group. Am.J.Epidemiol. 1993;137:749-57.
2. Ivanisevic M. The natural history of untreated rhegmatogenous retinal detachment. 
Ophthalmologica 1997;211:90-2.
3. La Heij EC, Hendrikse F. [Retinal detachments and retinal surgery]. Ned.Tijdschr.
Geneeskd. 1999;143:781-5.
4. Young TL, Ronan SM, Alvear AB, Wildenberg SC, Oetting WS, Atwood LD et al. A 
second locus for familial high myopia maps to chromosome 12q. Am.J.Hum.Genet. 
1998;63:1419-24.
5. Young TL, Ronan SM, Drahozal LA, Wildenberg SC, Alvear AB, Oetting WS et al. 
Evidence that a locus for familial high myopia maps to chromosome 18p. Am.J.Hum.
Genet. 1998;63:109-19.
6. Naiglin L, Gazagne C, Dallongeville F, Thalamas C, Idder A, Rascol O et al. A 
genome wide scan for familial high myopia suggests a novel locus on chromosome 
7q36. J.Med.Genet. 2002;39:118-24.
7. Schwartz M, Haim M, Skarsholm D. X-linked myopia: Bornholm eye disease. 
Linkage to DNA markers on the distal part of Xq. Clin.Genet. 1990;38:281-6.
8. Graemiger RA, Niemeyer G, Schneeberger SA, Messmer EP. Wagner vitreoretinal 
degeneration. Follow-up of the original pedigree. Ophthalmology 1995;102:1830-9.
9. Stickler GB. Hereditary progressive arthro-ophthalmopathy. Mayo Clin.Proc. 
1965;40:433-55.
10. Stickler GB, Pugh DG. Hereditary progressive arthro-ophthalmopathy II. Additional 
observations on vertebral abnormalities, a hearing defect, and a report of a similar 
case. Mayo Clin.Proc. 1967;42:495-500.
11. Lucarini JW, Liberfarb RM, Eavey RD. Otolaryngological manifestations of the 
Stickler syndrome. Int.J.Pediatr.Otorhinolaryngol. 1987;14:215-22.
12. Liberfarb RM, Goldblatt A. Prevalence of mitral-valve prolapse in the Stickler 
syndrome. Am.J.Med.Genet. 1986;24:387-92.
13. Snead MP, Payne SJ, Barton DE, Yates JR, al Imara L, Pope FM et al. Stickler 
syndrome: correlation between vitreoretinal phenotypes and linkage to COL 2A1. 
Eye 1994;8 ( Pt 6):609-14.
14. Snead MP, Yates JR, Pope FM, Temple IK, Scott JD. Masked confirmation of linkage 
between type 1 congenital vitreous anomaly and COL 2A1 in Stickler syndrome. 
Graefes Arch.Clin.Exp.Ophthalmol. 1996;234:720-1.
15. Snead MP, Yates JR. Clinical and Molecular genetics of Stickler syndrome. J.Med.
Genet. 1999;36:353-9.
Chapter 4 - Autosomal dominant rhegmatogenous retinal detachment
99
16. Richards AJ, Yates JR, Williams R, Payne SJ, Pope FM, Scott JD et al. A family 
with Stickler syndrome type 2 has a mutation in the COL11A1 gene resulting in 
the substitution of glycine 97 by valine in alpha 1 (XI) collagen. Hum.Mol.Genet. 
1996;5:1339-43.
17. Martin S, Richards AJ, Yates JR, Scott JD, Pope M, Snead MP. Stickler syndrome: 
further mutations in COL11A1 and evidence for additional locus heterogeneity. Eur.
J.Hum.Genet. 1999;7:807-14.
18. Brunner HG, van Beersum SE, Warman ML, Olsen BR, Ropers HH, Mariman EC. 
A Stickler syndrome gene is linked to chromosome 6 near the COL11A2 gene. Hum.
Mol.Genet. 1994;3:1561-4.
19. Vikkula M, Mariman EC, Lui VC, Zhidkova NI, Tiller GE, Goldring MB et al. 
Autosomal dominant and recessive osteochondrodysplasias associated with the 
COL11A2 locus. Cell 1995;80:431-7.
20. Sirko-Osadsa DA, Murray MA, Scott JA, Lavery MA, Warman ML, Robin NH. 
Stickler syndrome without eye involvement is caused by mutations in COL11A2, the 
gene encoding the alpha2(XI) chain of type XI collagen. J.Pediatr. 1998;132:368-
71.
21. Wilkin DJ, Mortier GR, Johnson CL, Jones MC, De Paepe A, Shohat M et al. 
Correlation of linkage data with phenotype in eight families with Stickler syndrome. 
Am.J.Med.Genet. 1998;80:121-7.
22. Wagner H. Ein bisher unbekanntes Erbleiden des Auges (Degeneratio hyaloideo-
retinalis hereditaria), beobachtet im Kanton Zürich. Klin.Monatsbl.Augenheilkd. 
1938;100:840-57.
23. Böhringer HR, Dieterle P, Landolt E. Zur Klinik und Pathologie der Degeneratio 
hyaloideo-retinalis hereditaria (Wagner). Opthalmologica 1960;139:330-8.
24. Jansen LMAA. Degeneratio hyaloideo-retinalis hereditaria. Opthalmologica 
1962;144:458-64.
25. Perveen R, Hart-Holden N, Dixon MJ, Wiszniewski W, Fryer AE, Brunner HG et 
al. Refined genetic and physical localization of the Wagner disease (WGN1) locus 
and the genes CRTL1 and CSPG2 to a 2- to 2.5-cM region of chromosome 5q14.3. 
Genomics 1999;57:219-26.
26. Brown DM, Kimura AE, Weingeist TA, Stone EM. Erosive vitreoretinopathy. A new 
clinical entity. Ophthalmology 1994;101:694-704.
27. Brown DM, Graemiger RA, Hergersberg M, Schinzel A, Messmer EP, Niemeyer G et 
al. Genetic linkage of Wagner disease and erosive vitreoretinopathy to chromosome 
5q13-14. Arch.Ophthalmol. 1995;113:671-5.
28. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM et al. The 
human genome browser at UCSC. Genome Res. 2002;12:996-1006.
29. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A et al. A comprehensive 
genetic map of the human genome based on 5,264 microsatellites. Nature 
1996;380:152-4.
Chapter 4 - Autosomal dominant rhegmatogenous retinal detachment
100
30. Rikken-Bultman DG, Wellink L, van Dongen PW. Hypermobility in two Dutch 
school populations. Eur.J.Obstet.Gynecol.Reprod.Biol. 1997;73:189-92.
31. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting 
DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
32. Lathrop GM, Lalouel JM, Julier C, Ott J. Strategies for multilocus linkage analysis in 
humans. Proc.Natl.Acad.Sci.U.S.A 1984;81:3443-6.
33. Lathrop GM, Lalouel JM. Easy calculations of lod scores and genetic risks on small 
computers. Am.J.Hum.Genet. 1984;36:460-5.
34. Lathrop GM, Lalouel JM, White RL. Construction of human linkage maps: likelihood 
calculations for multilocus linkage analysis. Genet.Epidemiol. 1986;3:39-52.
35. Bateman JF, Freddi S, Lamande SR, Byers P, Nasioulas S, Douglas J et al. Reliable 
and sensitive detection of premature termination mutations using a protein truncation 
test designed to overcome problems of nonsense-mediated mRNA instability. Hum.
Mutat. 1999;13:311-7.
36. Wilkin DJ, Liberfarb R, Davis J, Levy HP, Cole WG, Francomano CA et al. Rapid 
determination of COL2A1 mutations in individuals with Stickler syndrome: analysis 
of potential premature termination codons. Am.J.Med.Genet. 2000;94:141-8.
37. Stickler GB, Hughes W, Houchin P. Clinical features of hereditary progressive arthro-
ophthalmopathy (Stickler syndrome): a survey. Genet.Med. 2001;3:192-6.
38. Szymko-Bennett YM, Mastroianni MA, Shotland LI, Davis J, Ondrey FG, Balog JZ 
et al. Auditory dysfunction in Stickler syndrome. Arch.Otolaryngol.Head Neck Surg. 
2001;127:1061-8.
39. Richards AJ, Martin S, Yates JR, Scott JD, Baguley DM, Pope FM et al. COL2A1 
exon 2 mutations: relevance to the Stickler and Wagner syndromes. Br.J.Ophthalmol. 
2000;84:364-71.
40. Parentin F, Sangalli A, Mottes M, Perissutti P. Stickler syndrome and vitreoretinal 
degeneration: correlation between locus mutation and vitreous phenotype. Apropos 
of a case. Graefes Arch.Clin.Exp.Ophthalmol. 2001;239:316-9.
41. McLeod D, Black GC, Bishop PN. Vitreous phenotype: genotype correlation in 
Stickler syndrome. Graefes Arch.Clin.Exp.Ophthalmol. 2002;240:63-5.
42. Mayne R, Brewton RG, Mayne PM, Baker JR. Isolation and characterization of 
the chains of type V/type XI collagen present in bovine vitreous. J.Biol.Chem. 
1993;268:9381-6.
43. Kuivaniemi H, Tromp G, Prockop DJ. Mutations in fibrillar collagens (types I, II, III, 
and XI), fibril- associated collagen (type IX), and network-forming collagen (type 
X) cause a spectrum of diseases of bone, cartilage, and blood vessels. Hum.Mutat. 
1997;9:300-15.
44. Ballo R, Beighton PH, Ramesar RS. Stickler-like syndrome due to a dominant 
negative mutation in the COL2A1 gene. Am.J.Med.Genet. 1998;80:6-11.
Chapter 4 - Autosomal dominant rhegmatogenous retinal detachment
101
45. Richards AJ, Baguley DM, Yates JR, Lane C, Nicol M, Harper PS et al. Variation in 
the vitreous phenotype of Stickler syndrome can be caused by different amino acid 
substitutions in the X position of the type II collagen Gly-X-Y triple helix. Am.J.Hum.
Genet. 2000;67:1083-94.
46. Freddi S, Savarirayan R, Bateman JF. Molecular diagnosis of Stickler syndrome: a 
COL2A1 stop codon mutation screening strategy that is not compromised by mutant 
mRNA instability. Am.J.Med.Genet. 2000;90:398-406.
Chapter 4 - Autosomal dominant rhegmatogenous retinal detachment
102
C
hapter
Exclusion of COL2A1 
gene involvement 
in 12 small families 
with nonsyndromic 
rhegmatogenous retinal 
detachment
Alessandra Maugeri
Sioe Lie Go
Carel B. Hoyng
Frans P.M. Cremers
5
Chapter 5 - Exclusion of COL2A1 gene in nonsyndromic retinal detachment
104
Chapter 5 - Exclusion of COL2A1 gene in nonsyndromic retinal detachment
105
5.1 Introduction
Rhegmatogenous retinal detachment (RRD) is a frequent phenomenon which, if 
untreated, generally leads to blindness.1 Epidemiologic studies have estimated the 
incidence of RRD as 1:10,000 per individual per year in Caucasians.2-5 RRD occurs 
predominantly in individuals between 40 and 70 years of age which have no family 
history for retinal detachment.6 This hampers the identification of individuals at risk, 
who could benefit from preventive treatments or improved prognosis of surgery by an 
early diagnosis. 
Known risk factors for RRD are (high) myopia (-1.00 D to - 3.00 D: 4-fold risk; 
< - 3.00 D: 10-fold risk), lattice degeneration, posterior vitreous detachment and 
peripheral retinal degeneration.7-10 Moreover, cataract extraction and traumas can 
significantly increase the risk for RRD.6;11 
In isolated patients, RRD can be considered to be a multifactorial disorder. In a recent 
study, Go et al. demonstrated a higher incidence of RRD independent of age, sex and 
myopia in siblings and offspring of patients with RRD.5 Siblings of subjects with 
nonsyndromic RRD exhibited a three times increased frequency of RRD compared to 
siblings of unaffected subjects. These findings point to the presence of genetic factors 
predisposing to nonmendelian RRD, but to date none of these are known.
RRD also occurs in specific syndromes (e.g. in Stickler syndrome) and 
vitreoretinopathies (e.g. Wagner disease). For some of these monogenic disorders, the 
genetic bases have been elucidated. Most cases of Stickler syndrome are caused by 
mutations in the COL2A1 and COL11A1 genes, both genes encoding collagen molecules 
which are essential components of the vitreous.12-18 Mutations in the COL11A2 gene, 
which is not expressed in the vitreous, have been reported in the non-ocular Stickler 
syndrome phenotype.19;20 Moreover, exclusion of linkage to COL2A1 and COL11A1 
in several families with the full Stickler phenotype indicated the involvement of other 
yet unknown genes in this syndrome.14;17
In the last years, a number of families have been described which showed RRD with 
absent or minimal systemic features typical of Stickler syndrome, and which were 
associated with mutations in the COL2A1 gene.18;21-27 Most of these mutations were 
located in exon 2 of COL2A1, which is subject to alternative splicing.21-26 The COL2A1 
mRNA variant containing exon 2 is specifically expressed in the vitreous, thereby 
explaining the phenotype of patients in these families in which clinical features 
are restricted to the eye. In a previous study, we described two large families with 
nonsyndromic autosomal dominant rhegmatogenous retinal detachment (adRRD).18 
Candidate gene analysis showed linkage with a chromosomal region harbouring the 
COL2A1 gene. In one of these families, COL2A1 mutation analysis of genomic DNA 
and cDNA failed to identify a pathologic change.18 However, in the other family, a 
p.Arg453X mutation, previously described in a patient with Stickler syndrome, was 
found in exon 30 of the COL2A1 gene.18 The location of the mutation in this family 
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was surprising, due to the phenotype exhibited by the 12 affected members of this 
family, none of which presented with systemic features typical of Stickler syndrome. 
In order to explain our findings, we hypothesized the presence of a modifier locus, 
acting in trans, in the vicinity of the COL2A1 locus. In this way, a favourable allele 
could co-segregate in the family in combination with the mutation. The findings in 
family B were unprecedented and raised the question if mutations in the COL2A1 
gene could underlie a higher number of adRRD cases than expected based on previous 
knowledge. 
In this study, we investigated 12 small families with RRD. Most of these families 
exhibit a pattern of inheritance suggestive of a mendelian autosomal dominant trait. 
Linkage data and mutation analysis excluded the involvement of the COL2A1 gene in 
the majority if not all of these families, suggesting that mutations in the COL2A1 gene 
do not play a major role in familial RRD. 
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5.2 Materials & methods
Family recruitment and clinical investigations
Patients with RRD ascertained at the Department of Ophthalmology of the Radboud 
University Nijmegen Medical Centre between 2000 and 2003 were assessed for familial 
occurrence of RRD. Twelve families with RRD were anamnestically recognized and 
included in the present study (Figure 5.1). In total, 113 family members gave informed 
consent and had blood drawn for genetic analysis. Clinical charts of cooperating 
family members were reviewed. When necessary, further clinical examinations were 
performed. Clinical investigations included medical history (with special attention 
for ophthalmologic, audiologic, cardiac and orthopaedic disorders), visual acuity and 
intraocular pressure measurement, slit lamp biomicroscopy, fundoscopy, binocular 
contactglass examination and a physical examination including a Beighton score 
assessment for hypermobility where appropriate.
Individuals were considered affected when a retinal break and/or a rhegmatogenous 
retinal detachment was found or described. All others were considered unaffected.
Molecular genetic analysis
From all participating family members, blood samples were taken and DNA was 
extracted according to a protocol adapted from Miller et al.28
The proband of each family with RRD underwent COL2A1 exon 2 mutation analysis 
by direct sequencing (BigDye Terminator on a Prism 377; Applied Biosystems, Foster 
City,CA) of exon 2 and intron-exon boundaries (primers and conditions available on 
request).
Linkage analysis was performed on all 12 families with RRD using fluorescent-
labelled microsatellite markers. Two markers proximal to the COL2A1 gene [D12S85 
(AFM122xf6) and D12S1701 (AFM345xf1)] and two distal markers [D12S1661 
(AFMb314yh5) and D12S339 (AFM294wc5)] were chosen. DNA fragments were 
amplified using a GeneAmpPCR buffer and AmpliTaq Gold (Applied Biosystems), 
with 2.0 mM MgCl2 for all markers except D12S1701, which required 3.0 mM MgCl2. 
PCR conditions included a first round of 15 cycles with a standard cycling profile 
(94°C x 15”, 55°C x 15”, 72°C x 30”), followed by a second round of 25 cycles with 
a lower denaturating temperature (89°C).  PCR samples were pooled and analysed 
using a 3730 DNA Analyzer (Applied Biosystems). 
In a few families, a polymorphic change in the COL2A1 gene (c.504C>A in family 
W00-428; c.2195-55T>CG in family W02-168, W03-032, and W03-053 [RNA 
accession no. NM_001844; A of the ATG transcription starting codon as nucleotide 
1]) was used as an additional marker.
Two-point linkage analysis was performed using the MLINK routine of the LINKAGE 
program package Version 5.2. RRD was analyzed as an autosomal dominant trait 
with incomplete age-dependent penetrance and a gene frequency of 0.0001. The 
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Figure 5.1 Pedigrees of the 12 families segregating RRD described in this study
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penetrance was defined as the probability P (affected before current age), which is a 
cumulative distribution function of the age of onset. We assumed a penetrance of zero 
for individuals up to 5 years of age, and an age of onset uniformly distributed with 
a maximum penetrance of 0.95 at age 75. Age classes were (6-10), (11-15), etc. The 
penetrance P was calculated at the midpoint of each age class as P = [0.95/(75-5)] x 
(age-5). Because of the high occurrence of retinal detachment cases of multifactorial 
(non-mendelian) origin in the population, phenocopies were also introduced in this 
model. Based on the estimated cumulative lifetime risk of RRD as a function of 
age reported by Go et al.5, the probability of phenocopies was considered zero up 
to 30 years of age, reaching a relative maximum of 0.005 at 65 years of age, and a 
maximum of 0.03 at 85 years of age. The age-dependent distribution of the probability 
of phenocopies F was described by the equations F1 = [0.005/(65-30)] x (age-30) 
from 0 to 65 years, and F2 = [(0.03-0.005)/(85-65)] x (age-65) + 0.005 from 65 to 85 
years of age.
Probands of family P01-2058 and W02-140 were screened for COL2A1 mutations by 
direct sequencing of all 54 exons and exon-intron boundaries of the COL2A1 gene 
(primers and conditions available on request). 
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5.3 Results
Clinical features in patients with RRD
Clinical findings in probands of all families included in this study are summarized in 
Table 5.1, and are representative for the findings in these families. In total, 48 affected 
individuals were ascertained. In a few cases, affection status could not be established 
because preventive laser treatment had been performed (P94-161:II-1; W00-428:II-6 
and III-2; P01-2058:II-1; W02-140:II-3; W02-143:III-4), because RRD had occurred 
after a trauma (W03-053:II-3) or because of incompleteness of clinical information 
(P94-161:II-5; W01-126:III-6; W02-168:II-6; W03-032:III-2; W03-036:III-4 [affected 
by hearsay]; W03-164:II-4) (Figure 5.1). Information on deceased parents in the first 
generation was generally not available. Affected individual III-2 in family W02-168 
refused cooperation. In families W00-428 and W02-140, only a branch of the family 
(in grey box in Figure 5.1) entered this study.
In none of the families a typical RRD-causing syndrome was identifiable.
Mendelian inheritance of RRD 
Ten out of 12 analyzed pedigrees showed a pattern of RRD cases suggestive of a 
dominant mode of inheritance (Figure 5.1). However, in family W01-126 all 
affected individuals in three generations are females. In the absence of male to male 
transmission, dominant X-linked inheritance can not be excluded. In one pedigree 
(W01-206), all affected individuals belong to the same generation and are males, 
therefore indicating a possible recessive or X-linked transmission of the disorder. 
Due to the uncertain status of individual III:4, who underwent laser treatment, also in 
pedigree W02-143 a recessive mode of transmission cannot be excluded. 
Table 5.1 Clinical features in probands of the 12 families with RRD included in this study (See 
next page)
+ present, - absent, RRD = Rhegmatogenous retinal detachment, PVD = Posterior vitreous 
detachment, MH = macular hole, HS = horseshoe shaped defect, RH = round hole, Lattice = 
peripheral lattice degeneration
* myopia grade prior to RRD or retinal break (using spherical equivalents): -1 mild 
hypermetropia, 0 emmetropia, 1 mild (0 D to -1.5 D), 2 moderate (-1.5 D to -6.0 D), 3 high 
myopia (-6.0 or more)
†: Nontraumatic nuclear cataract at 42 yrs of age.
‡: Midfacial hypoplasia, cleft palate, hearing loss, articular abnormalities, cardiac abnorma-
lities
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Molecular genetic findings
COL2A1 exon 2 mutation analysis of the probands of the families with RRD included 
in this study failed to identify any nucleotide change in the coding region and in the 
flanking splice sites of this exon. 
Linkage analysis leads to a maximum cumulative 2-point lod score of 0.28 (Zmax) 
at theta 0.2 for marker D12S85 (Table 5.2). Lod scores for each family included in 
this study are reported in Table 5.3. Cumulative 2-point lod scores calculated for a 
subgroup of families which showed positive lod scores values for all or some of the 
markers flanking the COL2A1 gene (P94-161, P01-2058, W02-140, W03-032, and 
W03-053) did not reach statistical significance (Zmax = 2.31 at theta 0.000 for marker 
D12S339).
Table 5.2 Cumulative 2-point lod scores at the COL2A1 locus in 12 families with RRD
Marker Recombination Fraction
 0.000 0.100 0.200 0.300 0.400 0.500
D12S85 -2.93 0.10 0.28 0.21 0.09 0,00
D12S1701 -8.97 -0.95 -0.02 0.19 0.14 0,00
D12S1661 -7.84 -2.56 -1.15 -0.45 -0.11 0,00
D12S339 -7.15 -0.85 -0.05 0.25 0.17 0.00
Haplotype analysis failed to identify a single potential disease haplotype in the affected 
individuals of family W00-428, W01-126, W01-206, W02-143, W02-168, W03-036, 
and W03-164. In families W03-032 and W03-053, the putative disease haplotype 
was also present in two or more unaffected individuals. Finally, in family P01-2058, 
W02-140 and P94-161 haplotype analysis suggested linkage at the COL2A1 locus 
(Figure 5.2). Sequence analysis of all 54 exons and flanking intron-exon boundaries 
of COL2A1 in family P01-2058 and W02-140 did not reveal any pathological change 
in the coding region or at the exon splice sites of the COL2A1 gene. In family P94-161 
COL2A1 mutation analysis is ongoing.
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Table 5.3 Two-point lod scores at the COL2A1 locus in the 12 families with RRD included in 
this study 
Family no. Marker Recombination Fraction
 0.000 0.100 0.200 0.300 0.400 0.500
P94-161 D12S85 0,59 0,45 0,30 0,16 0,05 0,00
D12S1701 0,59 0,45 0,30 0,16 0,05 0,00
D12S1661 0,00 0,00 0,00 0,00 0,00 0,00
D12S339 0,59 0,45 0,30 0,16 0,05 0,00
P01-2058 D12S85 0,42 0,31 0,20 0,10 0,03 0,00
D12S1701 0,42 0,31 0,20 0,10 0,03 0,00
D12S1661 0,00 0,00 0,00 0,00 0,00 0,00
D12S339 0,42 0,31 0,20 0,10 0,03 0,00
W00-428 D12S85 0,05 0,04 0,03 0,02 0,01 0,00
D12S1701 0,05 0,04 0,03 0,02 0,01 0,00
COL2A1 c.504C>A -1,37 -0,46 -0,21 -0,09 -0,02 0,00
D12S1661 -1,36 -0,46 -0,21 -0,09 -0,02 0,00
D12S339 -1,35 -0,42 -0,18 -0,06 -0,01 0,00
W01-126 D12S85 -1,76 -0,27 -0,04 0,03 0,04 0,00
D12S1701 -1,77 -0,28 -0,05 0,03 0,04 0,00
D12S1661 -1,46 -0,48 -0,22 -0,09 -0,02 0,00
D12S339 0,37 0,31 0,25 0,17 0,09 0,00
W01-206 D12S85 -0,29 -0,22 -0,14 -0,07 -0,02 0,00
D12S1701 -0,29 -0,20 -0,11 -0,04 -0,01 0,00
D12S1661 -0,68 -0,21 -0,08 -0,03 -0,01 0,00
D12S339 -0,29 -0,20 -0,11 -0,04 -0,01 0,00
W02-140 D12S85 0,01 0,01 0,00 -0,01 -0,01 0,00
D12S1701 0,90 0,67 0,45 0,26 0,11 0,00
D12S1661 -0,10 -0,06 -0,03 -0,01 0,00 0,00
D12S339 1,21 0,93 0,64 0,36 0,14 0,00
W02-143 D12S85 -0,32 -0,20 -0,11 -0,05 -0,01 0,00
D12S1701 -0,44 -0,25 -0,12 -0,05 -0,01 0,00
D12S1661 -0,61 -0,36 -0,19 -0,08 -0,02 0,00
D12S339 -0,60 -0,34 -0,18 -0,08 -0,02 0,00
W02-168 D12S85 0,00 0,00 0,00 0,00 0,00 0,00
D12S1701 -1,80 -0,52 -0,22 -0,08 -0,02 0,00
COL2A1 c.2195-55T>CG -1,51 -0,42 -0,19 -0,07 -0,02 0,00
D12S1661 -1,43 -0,31 -0,12 -0,04 -0,01 0,00
D12S339 -1,83 -0,64 -0,30 -0,12 -0,03 0,00
W03-032 D12S85 0,05 0,00 -0,02 -0,01 0,00 0,00
D12S1701 0,12 0,05 0,01 0,00 0,00 0,00
COL2A1 c.2195-55T>CG -0,34 -0,16 -0,07 -0,03 -0,01 0,00
D12S1661 0,00 -0,01 -0,01 0,00 0,00 0,00
D12S339 0,03 -0,02 -0,03 -0,02 -0,01 0,00
W03-036 D12S85 -2,35 -0,49 -0,23 -0,10 -0,03 0,00
D12S1701 -4,94 -0,75 -0,30 -0,10 -0,02 0,00
D12S339 -3,35 -0,44 -0,19 -0,08 -0,02 0,00
W03-053 D12S85 0,00 0,00 0,00 0,00 0,00 0,00
D12S1701 0,07 0,04 0,02 -0,01 -0,01 0,00
COL2A1 c.2195-55T>CG 0,43 0,32 0,21 0,11 0,03 0,00
D12S1661 0,00 0,00 0,00 0,00 0,00 0,00
D12S339 0,06 0,04 0,02 -0,01 -0,01 0,00
W03-164 D12S85 0,65 0,47 0,28 0,13 0,03 0,00
D12S1701 -1,87 -0,54 -0,25 -0,10 -0,02 0,00
D12S1661 -2,20 -0,68 -0,30 -0,12 -0,03 0,00
D12S339 -2,41 -0,83 -0,38 -0,15 -0,04 0,00
Chapter 5 - Exclusion of COL2A1 gene in nonsyndromic retinal detachment
114
Fi
gu
re
 5
.2
 L
in
ka
ge
 a
na
ly
si
s i
n 
fa
m
ili
es
 P
94
-1
61
, P
01
-2
05
8 
an
d 
W
02
-1
40
W
02
-1
40
II
I:
1
48
 y
rs
10
9
12
1
95
10
1
?
?
26
7
27
5
D
12
S
85
D
12
S
17
01
D
12
S
16
61
D
12
S
33
9
II
I:
2
46
 y
rs
10
9
12
1
99
93
?
?
26
3
26
5
II
I:
3
42
 y
rs
12
1
12
1
10
1
93
25
7
24
9
26
9
26
5
IV
:1
16
 y
rs
10
9
10
9
95
99
?
?
26
7
26
3
D
12
S
85
D
12
S
17
01
D
12
S
16
61
D
12
S
33
9
IV
:3
12
 y
rs
10
9
12
1
95
93
?
?
26
7
26
5
IV
:2
15
 y
rs
10
9
10
9
95
99
?
?
26
7
26
3
II
:1
77
 y
rs
12
1
10
9
93
91
24
9
24
9
26
5
28
1
D
12
S
85
D
12
S
17
01
D
12
S
16
61
D
12
S
33
9
II
:4
10
9
95 24
9
26
9
69
 y
rs 1
09 10
1
24
9
28
1
I:
1
I:
2
(1
09
)
(1
21
)
(9
9)
(?
)
(?
)
(2
57
)
(2
63
)
(2
69
)
II
:2
II
:3
74
 y
rs
12
1
10
9
93
10
1
24
9
24
9
26
5
28
1
L
10
9
10
9
97
10
1
25
3
25
5
26
9
26
3
12
3
10
9
10
1
89
25
5
25
3
27
5
26
7
D
12
S
85
D
12
S
17
01
D
12
S
16
61
D
12
S
33
9
10
9
10
9
97
10
1
25
3
25
5
26
9
26
3
10
9
10
9
97
89
25
3
25
3
26
9
26
7
P
01
-2
05
8
?
II
:3
44
 y
rs
II
:4
41
 y
rs
II
:1
47
 y
rs
II
:2
45
 y
rs
I:
2
77
 y
rs
I:
1
78
 y
rs
10
9
10
9
10
1
89
25
5
25
3
26
3
26
7
10
9
12
3
97
10
1
25
3
25
5
26
9
27
5
D
12
S
85
D
12
S
17
01
D
12
S
16
61
D
12
S
33
9
I:
1
80
 y
rs
12
1
10
9
93
95
24
9
25
1
26
5
27
1
D
12
S
85
D
12
S
17
01
D
12
S
16
61
D
12
S
33
9
I:
2
79
 y
rs
10
9
10
9
95
97
25
1
24
9
26
1
27
5
10
9
10
9
95
95
25
1
25
1
27
1
26
1
D
12
S
85
D
12
S
17
01
D
12
S
16
61
D
12
S
33
9
12
1
10
9
93
95
24
9
25
1
26
5
26
1
12
1
10
9
93
95
24
9
25
1
26
5
26
1
12
1
10
9
93
97
24
9
24
9
26
5
27
5
10
9
10
9
95
97
25
1
24
9
27
1
27
5
10
9
10
9
95
97
25
1
24
9
27
1
27
5
II
:1
55
 y
rs
II
:6
41
 y
rs
? II
:5
43
 y
rs
II
:2
52
 y
rs
II
:4
45
 y
rs
II
:3
49
 y
rsP
94
-1
61
Chapter 5 - Exclusion of COL2A1 gene in nonsyndromic retinal detachment
115
5.4 Discussion
RRD is a frequent ophthalmologic finding.2-5 However, despite the relevance of RRD 
in clinical ophthalmology, an extensive analysis of nonsyndromic familial RRD has 
never been reported. In this study, we aimed to identify a sizeable group of RRD 
families, to assess the transmission of a mendelian trait, to describe the clinical features 
in familial RRD cases, and to investigate the role of the COL2A1 gene in adRRD.
In general, the size of the recruited families was small, with 3-6 affected individuals 
each. Up to now, genetic analysis has only been reported for 12 large families with 
adRRD distinct from Wagner disease and other well defined vitreoretinopathies.18;21-27 
Nine of these families showed typical ocular abnormalities found in Stickler syndrome 
with absent or minimal systemic features, and were due to mutations generating a stop 
codon in exon 2 of the COL2A1 gene.21-26 The remaining three families also showed 
linkage at 12q13.11-q13.2, an area encompassing the COL2A1 gene.18;27 In one of 
these families (family B18) we found a stop codon mutation p.Arg453X in exon 30 
of the COL2A1 gene. In family A no pathologic change was detected in the coding 
sequence, in the flanking intron-exon boundaries, and in known regulatory regions 
present in intron 1 and at the 3’UTR of the COL2A1 gene.18 Finally a family with 
adRRD carrying a novel p.Gly118Arg mutation, also located outside the alternatively 
spliced exon 2 region of COL2A1, has been recently described by Richards et al.27
As all published adRRD families were associated with mutations in the COL2A1 
gene, we evaluated the role of COL2A1 in our cohort of families. Sequence analysis 
failed to identify any pathologic variation in exon 2 of the COL2A1 gene in any of the 
probands of the 12 RRD families described here. Statistical analysis of linkage data 
in the families presented in this study is not simple. The first difficulty is the small 
size of the families. Only in case of a major disease locus, significant cumulative lod 
scores can be expected. Moreover, in a number of cases the affection status could not 
be established, further limiting the informativity of some of the families. A second 
drawback, is the frequent occurrence of late-onset RRD, which limits the informativity 
of the younger generations. We have taken this into account in the calculation of the 
lod scores by estimating the penetrance as a function of the age of onset. Penetrance 
at 75 years of age was assumed to be 95% based on data of families with RRD and 
COL2A1 mutations18;26 and refs therein and family A in Go et al.18, which all showed a high 
or complete penetrance above 70 years of age. Moreover, to account for the possible 
occurrence of “non-genetic or non-mendelian” cases of RRD in our families, an age-
dependent function for phenocopies was introduced in our model. Cumulative 2-point 
lod scores excluded COL2A1 as the disease locus in the majority of the 12 families with 
RRD. Moreover, lod scores did not reach statistical significance for any subgroup of 
these families. However, due to the small size of the families, lod score data could not 
exclude the involvement of COL2A1 in some of the families. In particular, haplotype 
analysis suggested linkage with COL2A1 for family P01-2058, W02-140 and P94-
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161. For this reason, probands of these families underwent sequence analysis of the 
entire COL2A1 gene. However, the failure to identify a pathological change in the 
protein coding sequence and the sequences flanking the exons of the COL2A1 gene 
in at least two of these families, strongly suggests that COL2A1 is not involved in the 
RRD pathology in these families. 
The identification of other monogenic causes of RRD through whole genome genetic 
linkage analysis is only feasible if only one or very few major loci exist. 
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6.1 Mutations in the COL2A1 gene as a cause for RRD
As shown in Chapters 4 and 5, we have studied two large families (families A and 
B) and twelve smaller multiplex families with nonsyndromic RRD. In both families 
A and B, we found statistically significant linkage with a region on chromosome 12 
containing the COL2A1 gene. This is depicted in Figure 6.1.
Figure 6.1 Linkage intervals of the RRD in families A and B
Genetic distances in centiMorgans (cM)
In humans, at least 27 collagen types are described, each of which consists of three 
polypeptide chains (α-chains), and each chain containing at least one domain of a 
repeating Gly-X-Y sequence. They can be subdivided in 9 subgroups, mainly on the 
basis of their structure and supramolecular organization. One of these subgroups 
consists of fibril-forming collagens and, among others, contains the type II and type 
XI collagens.1;2 Collagens of this subgroup can aggregate into highly orientated 
suprastructures of staggered arrangements of individual collagen monomers.3
Type II collagen is found in cartilaginous and ocular tissue (vitreous and cornea). The 
collagen type XI is found in collagen type II containing tissues, and forms the core of 
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collagen type II.4;5 Due to their torsional stability and tensile strength, these collagen 
types lead to integrity, and yet flexibility, of the tissues they are found in.1
The COL2A1 gene codes for a specific α-chain, called the α1(II)-chain. In collagen 
type II, three identical α1(II)-chains together form the typical trimer. Type XI collagen, 
unlike type II collagen, consists of three different α-chains. One of these chains consists 
of an unprocessed form of the α1(II)-chain encoded by COL2A1, which differs only in 
the extent of glycosylation and hydroxylation.1 The different α-chain compositions of 
collagen type II and collagen type XI are shown in Figure 6.2. 
Figure 6.2 Schematic α-chain compositions of collagen type II and collagen type XI in the 
vitreous body compared to cartilage
Sequence analysis of the COL2A1 gene was performed in both families. In family 
B, an Arg453Ter mutation in the COL2A1 gene was found. This mutation leads to 
nonsense-mediated decay of the mRNA and thus in COL2A1 haploinsufficiency 
in patients. Similar premature terminations causing haploinsufficiency in Stickler 
patients have been described.6 The exact Arg453Ter mutation had previously been 
reported in a sporadic patient with the type II Stickler syndrome, showing all classic 
abnormalities of the syndrome. Despite known variability of expression in Stickler 
syndrome, in a family as large as family B, the haploinsufficiency was predicted to 
result in systemic abnormalities in several patients, which was not the case.
A predominantly ocular subtype of the Stickler syndrome with mutations in COL2A1 
had been reported in several families.7-11 Table 6.1 lists patient characteristics of 10 
families with no or less extra-ocular manifestations with mutations in the COL2A1 
gene. One family also showing minimal extra-ocular abnormalities with a mutation 
in exon 2 of the COL2A1 gene was presented as a Wagner disease family, but the 
clinical description of the patients lacks crucial information to completely exclude a 
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predominantly ocular Stickler syndrome.12
The reason for the predominantly ocular expression of the Stickler syndrome was 
sought in alternative splicing of exon 2 in ocular tissue in comparison to cartilaginous 
tissue. In the latter, exon 2 is thought to be spliced out during the maturation process 
of the protein, resulting in collagen type IIB (see Figure 6.3), while in ocular tissue 
it is thought to remain part of the protein (type IIA). In cartilage, both type IIA and 
IIB are found, but the collagen type IIB predominates, whereas in the eye type IIA 
predominates. Therefore, a mutation in exon 2 is hypothesized to mainly affect the 
eye.7;13;14 However, the mutation found in family B without systemic abnormalities of 
Stickler syndrome was found outside exon 2, residing in exon 30.
Figure 6.3 Alternative splicing of exon 2 of the COL2A1 gene
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The afore-mentioned suggests that at least one other favourable genetic factor must 
be involved in family B. We postulate two possibilities for the localisation of this 
factor. 1. Family B belongs to a relatively closed religious community in a specific 
region in the Netherlands. Therefore, a possible shared genetic background within 
this community could have become more pronounced in this family. The favourable 
genetic factor(s) could then reside anywhere in the genome. 2. The genetic factor 
resides near the COL2A1 gene. It is known that the regulation of expression of most 
genes occurs at the level of transcription, but it can also occur downstream in the 
complex posttranslational modification of COL2A1. Transcription factors generally 
bind within 200 base pairs at the 5’ end of a gene. They are generally thought to 
be trans-acting, and act on both gene copies, as opposed to the regulatory promoter 
elements, in which cis-acting regulation on the nearby located gene is expected.18 
However, the greater the distance between the genetic co-factor and the COL2A1 gene, 
the greater the chance that meiotic crossovers will disrupt the link between COL2A1 
and the genetic co-factor. In family B, such a disruption could result in the full-blown 
Stickler syndrome in future offspring. Hypothetically, the genetic co-factor could 
lead to an upregulation of the transcription of the protein from the normal (wildtype) 
COL2A1 allele, partially compensating for the haploinsufficiency. Alternatively, there 
could be a downregulation of the expression of genes that, together with the COL2A1 
protein, form the trimeric collagen type XI, the COL11A1 and COL11A2 genes. These 
two possibilities are depicted in Figure 6.4 (see next page).
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Figure 6.4 The effect of modifier factors on the transcription of collagen genes in family B
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A known gene in the vicinity of COL2A1, encoding a transcription factor with a 
regulatory effect on the COL2A1 gene, is the SP1 gene. SP1 induces the transcription 
of the α1(II) procollagen of the COL2A1 gene. Sp1 knock-out mice show retarded 
development and lethality around 11 days post-coitum, and SP1 overexpression studies 
have demonstrated partial repair of the chondrocyte phenotype.19;20 It is possible that 
this gene is overexpressed in family B, resulting in a close to normal chondrocytic 
repair, leaving patients of this family with a close to normal phenotype except for an 
abnormal vitreous. Alternatively, abnormalities in other transcription factors with a 
downregulating ability on the binding of SP1, like for example SP3 (Sp3 transcription 
factor) and IL1B (interleukin 1, beta), could also be involved.20;21
This theory would, in a similar fashion, also explain the inter- and intrafamilial 
variability of Stickler syndrome. The question is whether this hypothetical genetic 
factor co-segregating with the COL2A1 mutation in family B has any relationship 
with the cause of RRD in family A.
In family A, we have sequenced all exons of the COL2A1 gene with at least 30 base 
pairs of the flanking intron sequence. We failed to find the causative mutation. Possibly, 
we have missed a mutation residing far away in one of the incompletely sequenced 
introns, a mutation in the promoter region, or a mutation outside the gene. A mutation 
in the afore-mentioned putative co-factor resulting in an incomplete function could 
also have caused the retinal detachments.
Recently, a second report of an autosomal dominant RRD family without systemic 
abnormalities of Stickler syndrome with a mutation outside exon 2 was published. 
The identified Gly118Arg mutation in this family resided in exon 15. Missplicing due 
to the mutation was excluded as an explanation for the mild phenotype, and it was 
concluded that the mutation seems to disrupt the collagen helix and/or fibril formation 
less than expected from other missense mutations that result in severely systemically 
affected phenotypes due to a dominant negative effect.17
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6.2 The role of the COL2A1 gene in smaller multiplex RRD 
families
Based on linkage analysis, in three of the twelve smaller families, the genetic defect 
could reside in or near the COL2A1 gene. In the nine remaining smaller multiplex 
families, the involvement of COL2A1 has not been demonstrated. This implies that 
more than one gene is involved in RRD. Unlike the situation in other tissues, in the 
vitreous body the COL11A2 derived third α-chain of collagen type XI is replaced by 
a COL5A2 derived α-chain. The COL5A2 gene therefore is a good candidate gene for 
linkage analysis in RRD families.
As hypothesized for family B, other similar pathways involving co-factors could 
possibly be involved in other subtypes of the Stickler syndrome with ocular 
abnormalities. For this reason, the possible involvement of COL11A1 and COL5A2 in 
the development of RRD in these families will also be investigated, in addition to the 
in Chapter 4 described candidate genes or loci.
However, there is another explanation for exclusion of COL2A1 (and other genes). 
The smaller families consist of only 2 to 7 affected individuals. Due to this limited 
number of affected individuals, there is a chance that in some of these families the 
cause for RRD is polygenic, which stresses the importance of epidemiological and 
statistical data, as described in the next paragraph.
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6.3 Epidemiology and clinical implications
In Chapter 2, it was shown that a genetic predisposition for nonsyndromic RRD 
exists, apart from myopia. This genetic component of RRD is mainly expressed in 
a limited number of families who show multiple first degree relatives with RRD. 
Two out of 181 families (1.2%) with an affected proband show two or more affected 
relatives (siblings and children), whereas only one out of 408 control families (0.2%) 
has at least two relatives with a retinal detachment. (See Table 2.3) The affected 
relatives demonstrate an onset at younger ages than the relatives of controls, but a 
statistically significant difference was reached only for ages of 69 years or higher.
A comparison with other ophthalmic disorders in which genetic factors have been 
investigated is difficult, but seems interesting to outline the magnitude of the genetic 
risk identified. Comparison with age-related macular degeneration seems inappropriate 
because the phenotype, unlike the retinal detachment as known so far, is influenced 
by environmental factors, such as diet and smoking.22 Therefore, the parameters of 
comparison would be unclear.
A comparison with primary open-angle glaucoma would be more appropriate, although 
also in this disorder the causative mechanism has not completely been identified. 
A positive family history for glaucoma is considered as a major risk factor in the 
development of primary open angle glaucoma, because the prevalence of glaucoma in 
siblings (10.4%) and offspring (1.1%) of glaucoma patients is considerably higher than 
in those of controls (0.7% and 0.0% respectively).23 The prevalence rate for siblings 
and offspring of nonsyndromic RRD patients (13/1090= 1.2%) was also higher than 
the prevalence rate for those of unaffected controls (9/2345= 0.4%). The estimated 
lifetime absolute risk at 80 years of age is 9.2 times higher for relatives of glaucoma 
patients compared to relatives of healthy controls, whereas in nonsyndromic RRD the 
lifetime absolute risk at 85 years of age is only 2.6 times higher.23 These data suggest 
that RRD has a smaller genetic component than primary open-angle glaucoma. 
The magnitude of the genetic predisposition by RRD proband status is also less than 
the genetic predisposition due to myopia, as shown in Chapter 2 and as compared with 
a more recent family aggregation study in high myopia estimates a sibling recurrence 
risk of 10.0%, whereas the sibling recurrence risk ratio was estimated 4.9%, based 
on the age of onset of spectacle wear, which was assumed to correlate with the final 
degree of myopia. Unfortunately, in that study offspring was not studied.24 A negative 
refractive error appears to enhance the risk of RRD among relatives both in the case 
group and the control group, but the risk is highest for relatives of RRD patients. This 
may indicate that myopia genes can interact with other genetic determinants, or in this 
case, with the RRD genes. The actual myopia genes are yet unknown, but in a recent 
study using a genomewide scan in dizygotic twins loci were found on chromosomes 
3q26, 4q12, 8p23 and 11p13 (amongst others harbouring the PAX6 gene).25 For 
high myopia, five different loci are currently known: chromosome Xq28, 7q36, 
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12q21-q23, 17q21-q22 and 18p11.31.26-30 For the more common mild to moderate 
myopia, another recent study has shown linkage evidence on chromosome 22q12.31 
Interestingly, interaction between myopia and proband status in our study was not 
statistically significant, implying that these two factors exist mainly independent of 
each other, and by deduction, that myopia and RRD may involve different genes. This 
conclusion was supported by reports of families with autosomal dominant RRD with 
a large range of refractive errors from slightly hyperopic to severe myopia, or even 
without myopia.16;32;33 Based on our data, however, it cannot be excluded that some 
RRD genes will be found within the same loci as those of myopia, or will even involve 
the same genes.
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6.4 Clinical implications and future studies
Studies investigating the natural course of rhegmatogenous retinal detachments 
have revealed that they often lead to blindness if the condition remains untreated.34 
From the two large families studied in Chapter 3 we have concluded that autosomal 
dominantly inherited RRD appears at very young ages in comparison to the age of 
common, mostly sporadic RRD that appears mostly around the age of 50-60 years.35-
37
Another important difference with the regular RRD is the predominant presentation 
with multiple atrophic holes, whereas in the common RRD the predominant retinal 
break is the horseshoe-shaped tear. The atrophic hole, on the other hand, is generally 
regarded as relatively harmless and does not very often require treatment.38
Furthermore, the patients in our study have a relatively bad prognosis, needing 
multiple surgical procedures to achieve retinal reattachment. In the majority of cases, 
visual acuities do not exceed 20/63 in the end. Common RRD prognoses are relatively 
better in the sense that they need less reoperations: 76-85% of the RRD patients has 
an attached retina after one surgical procedure, whereas in families A and B a mean 
number of 2.4 and 2.5 reoperations was necessary. The final visual acuity in common, 
sporadic RRD is 6/18 or better in 46%.39 In macula-off RRD the mean final visual 
acuity is 6/24, and a visual acuity of 6/12 or better is seen in 31-47%.40
With the mutation identified in the COL2A1 gene in one of these families, the 
possibility of genetic screening and counselling in this family has become available. 
Another benefit from our study lies in possible prevention of RRD in carriers of the 
COL2A1 mutation, for example with lasercoagulation or even preventive surgery. 
A recent study has demonstrated that preventive lasercoagulation of the entire 360 
degrees of the peripheral retina reduces the risk of bilaterality of RRD with 12.2% in 
fellow eyes when compared to untreated fellow eyes of RRD patients.41
In family B, genetic counselling has already been applied in some relatives, and in 
some young patients with the COL2A1 gene defect lasercoagulation has even been 
applied to prevent the children from the very likely development of RRD and its 
surgical consequences.
A prospective study will be necessary to reveal the best method of prevention in 
inherited RRD. The necessary preventive approach may differ from the common, 
sporadic RRD, because it appears that in hereditary RRD a considerable part of the 
problem may reside in the affected, atrophic peripheral retina causing the round 
atrophic holes, which may add to the risk of myopia and degeneration of the vitreous 
body.
Preliminary data from a histopathological study we performed, showed COL2A1 
protein staining in the wall of only peripheral retinal vessels, as shown in Figure 
6.5. The result was reproduceable in multiple slides and retinal specimens, but needs 
further investigation.
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However, the role of the COL2A1 protein in these vessels is still unclear, but possibly 
the lack of COL2A1 in the peripheral retinal vessels leads to a lesser quality of the 
construction or the maintenance of the peripheral retinal tissue, leading to peripheral 
atrophic holes. The cause of the known peripheral radial perivascular pigmentation 
in Stickler patients could possibly also be related to abnormalities of these vessels. 
Further histological studies of retinal tissue of healthy individuals and Stickler patients 
are required to explore this theory. Another approach to explore the magnitude of the 
theory could involve experiments of expression of the COL2A1 gene in tissue samples 
of the retina from different embryological stages, from healthy individuals and from 
Stickler syndrome patients.
 A  B
Figure 6.5 COL2A1 protein staining in the superficial retinal bloodvessels
Note the staining in the peripheral superficial bloodvessel walls (arrows) (A), as opposed to the 
absence of staining of the more centrally located vessels in the retina (B).
← ←
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7.1 Summary
Rhegmatogenous retinal detachment (RRD) is the most common type of retinal 
detachment. In this type of retinal detachment, a break in the neurosensory part 
of the retina allows fluid from the vitreous cavity to enter the space between the 
sensory retina and the retinal pigment epithelium. Yearly, approximately 1 in 10,000 
individuals presents with this disorder, and most RRDs occur between the ages of 
40 and 70 years. The fellow eye of affected individuals has a 4.2-19% risk of RRD 
development in the future. Whereas asymptomatic operculated and atrophic holes are 
generally considered quite harmless, flap tears and the less common retinal dialyses 
often progress to RRDs. Risk factors like myopia, vitreous degeneration, lattice 
degeneration, trauma and lens surgery can contribute to the development of RRD.
Untreated, RRD leads to blindness in the majority of cases. However, laser treatment 
and cryocoagulation in cases of retinal breaks without subretinal fluid and/or surgery 
in more advanced cases can often prevent further detachment or achieve reattachment 
of the retina. An anatomically good result can be achieved in about 95% of all cases.
In several nonsyndromic (e.g. myopia and Wagner disease) and syndromic inherited 
ophthalmic disorders (e.g. Stickler syndrome), retinal detachment is one of the disease 
features. Due to overlapping clinical features and the fact that many of the causative 
gene mutations are still unknown, it is sometimes difficult to distinguish between 
some of these disorders.
The aim of this thesis was to elucidate the genetic basis of retinal detachment, and 
subsequently to contribute to a better understanding of the disease and counselling 
of retinal detachment patients and their families. This may enable prevention or 
early treatment of the disorder in selected cases. We used different approaches: first, 
in an epidemiological study, we investigated the magnitude of the genetic risk of 
nonsyndromic RRD and the risk of relatives of RRD patients independent of other 
risk factors. Secondly, a clinical approach was used to investigate possible differences 
in presentation or in surgical prognosis in two large families with autosomal dominant 
nonsyndromic retinal detachments (families A and B). Finally, a genetic approach 
was used to investigate the genes involved in retinal detachment families, first in 
the two large autosomal dominant nonsyndromic retinal detachment families, and 
subsequently in 12 smaller families in order to investigate the extent of involvement 
of the COL2A1 gene in these.
To estimate the risk of RRD in relatives of RRD patients, we studied 2345 relatives 
of 408 healthy individuals (‘controls’) from a Dutch Caucasian population and 
1090 relatives of 181 patients with RRD (‘cases’), as described in Chapter 2. The 
yearly incidence of RRD in the Netherlands is 8.24 per 100,000 individuals. Thirteen 
relatives (1.2%) with RRDs were found in 10 case probands, while 9 relatives (0.4%) 
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of 8 control probands were diagnosed with RRD. The cumulative lifetime risk of RRD 
was 7.7% for the case relatives and 3.0% for control relatives, yielding a 2.6 times 
higher risk for RRD in case relatives. Myopia did not fully explain this increased risk. 
We concluded that familial occurrence of RRD is a risk factor for RRD, especially in 
families with more than two affected first degree relatives in two generations.
In surgery for retinal detachment, primary reattachment of the retina is achieved in 76-
85% of the cases, but as described earlier, an overall anatomically satisfactory result is 
eventually achieved in 90-95%. Surgery in inherited disorders like Stickler syndrome 
and Wagner disease, however, is frequently disappointing and recurrences of retinal 
detachments due to proliferative vitreoretinopathy occur frequently.
To investigate the surgical results in nonsyndromic inherited RRD, we studied the 
affected members of families A and B with an autosomal dominantly inherited RRD 
without classic ocular or systemic features of RRD-related syndromes, as described in 
Chapter 3. Medical records with an average of 7 years follow-up were retrospectively 
reviewed with a focus on preoperative, operative and postoperative data. 
The average age of onset in both families was lower than the age of onset in sporadic 
RRD cases, but was comparable with the age of onset of retinal detachment in heritable 
disorders. RRD in fellow eyes was found more often than expected from studies in 
sporadic RRD. The detachments predominantly resulted from a high number of round, 
atrophic holes, rather than the horseshoe tears as characteristically encountered in 
sporadic RRD. Again this was more comparable to the defects in heritable disorders 
with RRD like high myopia, Stickler syndrome and Kniest dysplasia. These results 
are suggestive of an intrinsic retinal fragility.
Furthermore, poor surgical results were found, independent of the surgical techniques 
used. In about half of the cases, mostly due to proliferative vitreoretinopathy 
formation, multiple operations were needed to reattach the retina. In some patients 
the retina remained detached. Final visual acuities were on average 20/80 in family 
A and 20/50 in family B, with a visual acuity of hand motions or worse in three out 
of ten patients of each family. The outcome of surgery pointed out the necessity of 
timely recognition of individuals at risk in autosomal dominant RRD families, and the 
need for prophylactic treatment of even asymptomatic round atrophic retinal defects 
in these cases. Because of the apparent intrinsic fragility of the peripheral retina, the 
reported posterior vitreous detachment after laser treatment and the high prevalence 
of proliferative vitreoretinopathy in our patients, we suggest that gentle prophylactic 
laser treatment should be applied to the peripheral retina, covering all quadrants in 
patients at risk.
In Chapter 4, we reported the result of the linkage analysis we performed in families 
A and B, in order to find the defective gene(s) involved. The analysis was performed 
in 28 individuals (15 affected) from family A and 22 individuals (12 affected) from 
family B. We first analyzed the three known loci for high myopia, the Wagner disease/
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erosive vitreoretinopathy locus, the nonsyndromic congenital retinal nonattachment 
locus and the predominantly ocular Stickler syndrome gene COL2A1. Significant 
LOD scores for both families were found in a region containing the COL2A1 gene on 
chromosome 12. In family A, no mutations in the coding regions and exon splice-sites 
of COL2A1 were found. In family B, however, an Arg453Ter mutation was found in 
this gene. The finding of this mutation was in two ways surprising: firstly, family B 
showed no Stickler characteristics, but this exact mutation and other similar protein 
truncating mutations until then had been associated with the classic Stickler syndrome. 
Secondly, reported families with a predominantly ocular phenotype of the syndrome, 
had always been associated with protein truncating mutations in exon 2, whereas this 
mutation was found in exon 30.
In Chapter 5 we investigated the role of the COL2A1 gene in the development of RRD 
in 12 smaller families. COL2A1 exon 2 and flanking splice-sites sequence analysis in 
all probands did not reveal any mutations. Linkage studies with markers from the 
region encompassing the COL2A1 gene showed cosegregation of the chromosomal 
region harbouring the COL2A1 gene in three families (families P01-2058, W02-140 
and P94-161). However, sequence analysis of the COL2A1 gene coding region and the 
intron-exon boundaries in at least two of the three families (P01-2058 and W02-140) 
did not reveal any mutation. These data suggest that the COL2A1 gene is not the major 
affected gene in smaller RRD families. In families P01-2058, W02-140 and family 
A, a mutation in a gene in the vicinity of COL2A1 cannot be excluded. In family A, 
the pathologic DNA sequence variant can be localized in any of the genes residing in 
the 21.6 cM region encompassing the COL2A1 gene. Furthermore, the exclusion of 
linkage with the COL2A1 region in at least 9 families indicates that at least one other 
locus outside this region must exist. Alternatively, RRD in these families is caused by 
several, and possibly even non-genetic, factors.
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7.2 Samenvatting
Het meest voorkomende type netvliesloslating is de rhegmatogene netvliesloslating 
(RRD). Bij dit type netvliesloslatingen komt er via een defect in het neurosensorische 
deel van de retina vocht uit de glasvochtruimte tussen de sensorische retina en het 
retinaal pigmentepitheel terecht. Ongeveer 1 op de 10.000 mensen per jaar krijgen 
de aandoening. De meeste RRD’s treden op bij een leeftijd van tussen de 40 en 70 
jaar. Het tweede oog van patiënten heeft een risico van 4.2-19% op een toekomstige 
netvliesloslating. Terwijl asymptomatische atrofische gaten en gaten met operculum 
(klepje) als vrij onschuldig worden gezien, vindt er bij flapscheuren en bij de in mindere 
mate voorkomende orascheuren vaker voortschrijding tot RRD plaats. Risicofactoren 
als myopie, glasvochtdegeneratie, lattice degeneratie, trauma en lenschirurgie kunnen 
bijdragen aan de vorming van RRD.
Als de RRD onbehandeld blijft, eindigt deze in de meerderheid van de gevallen in 
blindheid. Laserbehandeling en cryocoagulatie in gevallen met retinale defecten 
zonder subretinaal vocht en/of chirurgie in de meer voortgeschreden gevallen kan 
verdere loslating voorkomen, of het netvlies weer aanliggend doen maken. Een 
anatomisch goed resultaat wordt in ongeveer 95% van alle gevallen behaald.
In een aantal niet-syndromale (zoals bv. myopie en de ziekte van Wagner) en 
syndromale erfelijke oogaandoeningen (zoals bv. het Stickler syndroom) is een 
netvliesloslating een van de kenmerken. Doordat de aandoeningen klinische overlap 
vertonen en doordat veel van de ziekte veroorzakende genmutaties nog niet gevonden 
zijn, is het soms moeilijk de aandoeningen onderling van elkaar te onderscheiden.
Het doel van dit proefschrift was om de genetische basis van netvliesloslatingen te 
belichten, om daardoor bij te kunnen dragen aan een beter begrip van de aandoening 
en patiënten met netvliesloslatingen en hun families beter te kunnen voorlichten. 
Hierdoor kan er in bepaalde gevallen in de toekomst mogelijk preventie of behandeling 
in een vroeg stadium plaatsvinden. Er werden verschillende benaderingswijzen 
gebruikt: allereerst een epidemiologische studie, waarin we de omvang van het 
genetische risico van niet-syndromale RRD en het risico voor familieleden van RRD 
patiënten onafhankelijk van andere risicofactoren onderzochten. Vervolgens werd 
een klinische benadering aangewend om mogelijke verschillen in presentatie of in 
chirurgische prognose te onderzoeken in twee grote families met autosomaal dominant 
overervende niet-syndromale netvliesloslatingen (families A en B). Ten slotte volgde 
een genetische benadering, waarbij onderzocht werd welke genen betrokken waren bij 
familiaire netvliesloslatingen. Dit gebeurde eerst in de twee grote families A en B, en 
vervolgens, om te achterhalen in hoeverre het COL2A1-gen in deze betrokken was, in 
12 kleinere families.
Om het risico op RRD in familieleden van RRD patiënten te kunnen inschatten, 
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bestudeerden we 2345 familieleden van 408 gezonde individuen (“controles”) uit een 
Nederlandse Caucasische populatie en 1090 familieleden van 181 patiënten met RRD 
(“cases”) (Hoofdstuk 2). De jaarlijkse incidentie van RRD in Nederland bedraagt 
8,24 op de 100.000 personen. Dertien familieleden (1,2%) van 10 case probands 
bleken RRD’s te hebben, terwijl slechts 9 familieleden (0,4%) van 8 control probands 
een RRD hadden. Het cumulatieve risico voor RRD was 7,7% voor de familieleden 
van cases en 3,0% voor familieleden van controles, hetgeen resulteerde in een 2,6 
keer verhoogd risico op RRD voor familieleden van cases. Dit verhoogde risico kon 
niet geheel door myopie verklaard worden. We concludeerden dat het voorkomen van 
RRD in de familie een separate risicofactor is voor RRD, met name in families met 
meer dan twee aangedane eerstegraads familieleden in twee generaties.
Bij chirurgie voor netvliesloslatingen resulteert een eenmalige behandeling in 76-85% 
in een aanliggend netvlies, maar na meerdere operaties wordt uiteindelijk in 90-95% 
een anatomisch bevredigend resultaat bereikt. Bij erfelijke aandoeningen zoals het 
Stickler syndroom en de ziekte van Wagner zijn de chirurgische resultaten echter vaak 
teleurstellend en komen er door proliferatieve vitreoretinopathie vaak recidieven van 
de netvliesloslatingen voor.
Om de chirurgische resultaten bij niet-syndromaal overervende RRD te onderzoeken, 
bestudeerden we de aangedane familieleden uit families A en B met autosomaal 
dominant overervende RRD zonder de klassieke kenmerken van RRD-gerelateerde 
syndromen (Hoofdstuk 3). We onderzochten retrospectief de medische gegevens, 
met een gemiddelde follow-up tijd van 7 jaar. Hierbij werd speciale aandacht besteed 
aan pre-operatieve, operatieve en post-operatieve data.
De gemiddelde beginleeftijd van de RRD’s  in beide families was lager dan de 
gemiddelde beginleeftijd van sporadische RRD patiënten, maar hij was vergelijkbaar 
met de beginleeftijd van netvliesloslatingen in erfelijke aandoeningen. RRD in het 
tweede oog werd vaker aangetroffen dan op grond van studies in sporadische RRD 
verwacht werd. De RRD’s onstonden met name door een groot aantal ronde, atrofische 
gaten in plaats van door de flapscheuren die gewoonlijk worden aangetroffen bij 
sporadische RRD. Ook dit gegeven was meer vergelijkbaar met de defecten in 
erfelijke aandoeningen met RRD, zoals hoge myopie, het Stickler syndroom en Kniest 
dysplasie. Deze resultaten suggereerden een intrinsieke fragiliteit van het netvlies.
Verder werden er, onafhankelijk van de gebruikte chirurgische technieken, 
tegenvallende resultaten gevonden. In ongeveer de helft van het aantal gevallen waren 
er meerdere operaties nodig om het netvlies aanliggend te maken, meestal doordat 
er proliferatieve vitreoretinopathie optrad. Bij sommige patiënten bleef het netvlies 
afliggend. De uiteindelijke gezichtsscherpte was gemiddeld 0,25 in familie A en 0,4 
in familie B, waarbij in drie van de tien patiënten van elke familie slechts waarneming 
van handbewegingen of minder restte. De chirurgische resultaten toonden het belang 
van tijdige herkenning van individuen met een verhoogd risico in families met 
autosomaal dominant overervende RRD aan, maar ook dat zelfs bij asymptomatische, 
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ronde, atrofische retinadefecten profylactische behandeling nodig is in deze gevallen. 
Vanwege de klaarblijkelijke intrinsieke fragiliteit van de perifere retina, de bekende 
achterste glasvochtmembraanloslating na lasertherapie en het frequente voorkomen 
van proliferatieve vitreoretinopathie in onze patiënten, stellen wij voor bij patiënten 
met een verhoogd risico alle kwadranten van de perifere retina voorzichtig met 
lasercoagulatie te behandelen.
In Hoofdstuk 4 werd het resultaat van het koppelingsonderzoek dat wij in families 
A en B verrichtten om de betrokken gendefecten te achterhalen weergegeven. De 
analyse werd verricht in 28 individuen (15 aangedanen) van familie A en 22 individuen 
(12 aangedanen) van familie B. We onderzochten eerst de drie reeds bekende loci 
voor hoge myopie, het locus voor de ziekte van Wagner/erosieve vitreoretinopathie, 
het locus voor niet-syndromale, congenitale retinale ‘nonattachment’ en het bij 
‘predominantly ocular’ Stickler syndroom betrokken COL2A1-gen. In beide families 
werden significante LOD scores gevonden in een regio rond het COL2A1-gen op 
chromosoom 12. In familie A werden geen mutaties in de coderende gebieden en de 
exon splice-sites van COL2A1 gevonden. In familie B werd echter wel een Arg453Ter 
mutatie in dit gen gevonden. Deze bevinding was verrassend: ten eerste omdat familie 
B geen Stickler kenmerken vertoonde hoewel deze exacte mutatie en vergelijkbare 
mutaties die resulteren in onvolledig gesynthetiseerde eiwitten tot die tijd geassocieerd 
werden met het klassieke Stickler syndroom. Ten tweede werden families met een 
‘predominantly ocular’ fenotype van het Stickler syndroom tot dusverre altijd met 
mutaties in exon 2 geassocieerd, waarbij eveneens de COL2A1-translatie prematuur 
stopt, terwijl de gevonden mutatie in exon 30 aangetroffen werd.
In Hoofdstuk 5 onderzochten we de rol van het COL2A1-gen in de ontwikkeling van 
RRD in 12 kleinere families. Sequentie-analyse van exon 2 van het COL2A1-gen en 
de flankerende splice-sites liet geen mutaties zien. Koppelingsstudies met markers 
van de regio rond het COL2A1-gen lieten cosegregatie van de chromosomale regio 
met daarin het COL2A1-gen zien in drie families (families P01-2058, W02-140 en 
P94-161). Sequentie-analyse van de coderende gebieden van het COL2A1-gen en de 
intron-exon overgangen in ten minste twee van de drie families (P01-2058 en W02-
140) toonde echter geen mutaties aan. Deze data geven aan dat het COL2A1-gen 
niet het belangrijkste aangedane gen is in kleinere RRD families. In families P01-
2058, W02-140 en familie A kan een mutatie in een gen in de buurt van COL2A1 niet 
worden uitgesloten. In familie A zal de pathologische DNA-sequentievariant zich in 
een van de andere genen in de 21.6 cM regio rond het COL2A1-gen bevinden. Verder 
suggereert het ontbreken van koppeling met de COL2A1 regio in tenminste 9 families 
dat er minstens één ander locus buiten deze regio moet bestaan. Het is echter ook 
mogelijk dat de RRD in deze families wordt veroorzaakt door meerdere, mogelijk 
zelfs niet-genetische, factoren.
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Figure 1.6 The positions of macula, fovea and foveola in the posterior pole of the eye
Colour plates
Figure 1.8 Retinal detachment caused by a flap tear
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Figure 1.12 Complete retinal detachment. 
Note that the papilla centers all folds.
Figure 1.15 Situs inversus of the central retinal vessels in a patient with Wagner disease
Figure 1.14 Preretinal circular line at the equator in a patient with Wagner disease (arrow)
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Figure 4.2 COL2A1 mutation analysis in patient BII-6
(A) DNA sequence analysis of part of exon 30 (previously denoted as exon 28) of the COL2A1 
gene. Top: sequence of a control individual; bottom: sequence of the clinically affected 
individual BII-6, carrying a heterozygous C-to-T transition resulting in an Arg453Ter mutation. 
(B) RNA analysis of the Arg453Ter mutation in patient BII-6. Top: sequence of the cDNA of 
the patient. Because of mRNA instability, the transcript of the mutant allele was not detectable. 
Bottom: sequence of the cDNA of the patient obtained after incubation of lymphoblastoid cells 
in a medium containing cycloheximide, which prevents nonsense-mediated mRNA decay. 
Sequence analysis shows presence of transcripts from both the normal and the mutant allele.
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 A  B
Figure 6.5 COL2A1 protein staining (red) in the superficial retinal bloodvessels
Note the staining in the peripheral superficial bloodvessel walls (arrows) (A), as opposed to the 
absence of staining of the more centrally located vessels in the retina (B).
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